WO2018223743A1 - Silver-containing antibacterial product, and preparation method thereof - Google Patents
Silver-containing antibacterial product, and preparation method thereof Download PDFInfo
- Publication number
- WO2018223743A1 WO2018223743A1 PCT/CN2018/079095 CN2018079095W WO2018223743A1 WO 2018223743 A1 WO2018223743 A1 WO 2018223743A1 CN 2018079095 W CN2018079095 W CN 2018079095W WO 2018223743 A1 WO2018223743 A1 WO 2018223743A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- silver
- fiber
- alcohol amine
- fabric
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Definitions
- the invention relates to a silver-containing antibacterial product and a preparation method thereof, in particular to a silver-containing product containing a silver-containing alcohol amine chelate compound.
- the articles can be used in medical dressings and other antimicrobial fields.
- Chronic exudative wounds such as venous ulcers, arterial ulcers, diabetic ulcers, traumatic ulcers, and pressure ulcers caused by diseases such as diabetes, pressure sores, hemorrhoids, and hypertension seriously affect people's health.
- Exudative wounds are a type of chronic wound that secretes large amounts of exudate, while the main components of exudates are pus, tissue fluid, and some necrotic tissues and cells. Therefore, the care of chronic exudative wounds should not only fully absorb the wound exudate, but also provide a warm and moist healing environment for wound healing. Anti-infective care should also be carried out on the wound in time.
- the antibacterial silver-containing substances used in the dressings on the market are mainly some organic and inorganic salts of silver, such as silver nitrate, silver chloride, silver hypochlorite, silver carbonate, silver acetate, sodium zirconium phosphate, etc. .
- U.S. Patent No. 6,897,349 and European Patent No. 1,216,065 disclose the preparation of a silver-containing antibacterial material by dispersing silver chloride in the fibers during the preparation of the fibers.
- the material (chlorine) in the production of such wound dressings is highly corrosive to equipment.
- Citride CN1308509C discloses a silver-containing chitosan fiber having antibacterial action and a preparation method thereof, which comprises mixing silver compound particles having a particle diameter of about 1 micrometer, that is, sodium zirconium hydrogen phosphate (trade name: Alphasan) in spinning.
- the silver compound contains silver in an amount of from 3.0 to 4.0% by weight. Because Alphasan itself has a limited amount of silver, the silver content of the product is also small. In addition, the particle size of Alphasan is too large, which is detrimental to fiber strength.
- Ionic antibacterial dressings have a high efficiency in the use of silver, and most of the silver-containing antibacterial dressings on the market are mostly ionic.
- most of the silver compounds used in ionic silver-containing dressings are very low in water solubility, such as silver chloride, silver carbonate, etc., because of their low solubility in water, only a small amount of silver ions are ionized after water to reach equilibrium. When these small amounts of silver ions are consumed, the insoluble silver compound re-ionizes a small amount of silver ions, and the effect of sustained release of silver ions is achieved by such a dissolution balance.
- a low-water-soluble ionic silver-containing dressing can release silver ions continuously, but it releases less silver ions after water contact, so relatively more silver compounds are still needed to achieve the desired antibacterial effect.
- the release of silver in this type of wound dressing is generally performed.
- the amount of silver released in 10 ml of wound simulating solution is only about 20 ppm in 10 ml of wound simulant, which affects its antibacterial effect and effect to some extent.
- Time, in addition, most of the ionic silver-containing dressings are not stable, and the silver-containing dressings will change color after being left for a period of time, affecting their acceptability as a commercial appearance.
- silver-containing complexes as antibacterial agents, such as silver thiosulfate complexes and silver-ammonia complexes, but such silver-containing complexes are a class of inorganic chelate compounds that have good solubility in water.
- solubility in organic solvents such as ethanol is poor, which is quite disadvantageous for products which are gelled by water, such as carboxymethyl cellulose fiber products, carboxyethyl cellulose fiber products, and acylated chitosan fibers. product.
- the present invention discloses a silver-containing antibacterial article comprising a silver-containing alcohol amine chelate as an antibacterial component, and the silver-containing alcohol amine chelate compound is uniform. Distributing and incorporating to the interior and/or surface of the article, the article has a silver content of from 0.01 to 10% by weight, based on the weight of the article, and the article has a moisture absorption capacity of 6 g/g or more.
- the silver-containing alcohol amine chelate of the present invention has different isomers according to the length of the alcohol amine carbon atom chain, and the alcohol amine is an organic substance containing an amino group and a hydroxyl group, for example, different carbon chain lengths.
- the structure of the silver-containing alcohol amine chelate is as follows:
- the silver-containing alkamine chelate is a stable silver-centered chelate, and the silver ion and the alkanolamine molecule are chelated in a 1:2 form to form a soluble chelate.
- the alcohol amine can be gradually added dropwise to the dispersion of the silver-containing compound, and the dispersion of the silver-containing compound can be added dropwise to the alcohol amine until a uniform silver-containing alcohol amine chelate solution is obtained.
- the dispersion of the silver-containing compound means a precipitate, a colloid or a solution.
- a soluble silver-containing compound such as silver nitrate
- it should preferably be converted into a slightly soluble, poorly soluble or insoluble silver-containing compound, and then thoroughly mixed with the alcohol amine until the precipitate just dissolves.
- the silver-containing alcohol amine chelate of the present invention is obtained by thoroughly mixing a silver-containing substance with an alcohol amine, wherein the molar ratio of the alcohol amine to the silver ion is 1:1 to 10:1, preferably 1.5:1 to 3: 1.
- the silver-containing material is selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver acetate or silver oxalate, and the alcohol amine is an organic substance containing an amino group and a hydroxyl group.
- silver nitrate is first reacted with an appropriate excess of sodium hydroxide to form a poorly soluble silver oxide precipitate, and then ethanolamine is gradually added dropwise until the formed silver oxide precipitate just dissolves, thereby obtaining a clear and transparent Silver-containing ethanolamine chelate solution.
- the silver-containing antimicrobial article of the present invention is a silver-containing fiber, a silver-containing fabric, or a silver-containing polyurethane material, which can be obtained as follows:
- the alcohol amine is an organic substance containing an amino group and a hydroxyl group, wherein the molar ratio of the alcohol amine to the silver ion is 1:1 to 10:1, preferably 1.5:1 to 3:1;
- step (3) adding the silver-containing alcohol amine chelate to the mixture of the step (1), so that the fiber, fabric or polyurethane material is immersed at 25-80 ° C for 1-120 minutes, and then taken out and dried to obtain a A silver-containing antibacterial product is described.
- the silver-containing antimicrobial article of the present invention is a silver-containing fiber, a silver-containing fabric, or a silver-containing polyurethane material, which can be prepared as follows:
- step (1) immersing the fiber, fabric or polyurethane material in the alcohol amine solution of step (1);
- a silver-containing substance in a solvent to obtain a silver ion-containing solution or dispersion selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or oxalic acid Silver, the solvent being selected from the group consisting of ethanol, water, or a combination thereof;
- the article wherein the molar ratio of the alkanolamine to the silver ion is from 1:1 to 10:1, preferably from 1.5:1 to 3:1.
- the silver-containing antimicrobial article of the present invention is a silver-containing fiber, a silver-containing fabric, or a silver-containing polyurethane material, which can be obtained as follows:
- step (3) alkanolamine solution to the mixture of the step (2) at 25-80 ° C, and allowing to stand for 1-120 minutes, and then taking out and drying to obtain the silver-containing antibacterial article, wherein
- the molar ratio of the alkanolamine to the silver ion is from 1:1 to 10:1, preferably from 1.5:1 to 3:1.
- the silver-containing antimicrobial article of the present invention is a silver-containing fiber which can be prepared as follows:
- the fiber being selected from the group consisting of alginate fibers, chitosan fibers, viscose fibers, lyocell fibers or sea ray fibers;
- a silver-containing substance to the alcohol amine to obtain a silver-containing alcohol amine chelate selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or Silver oxalate
- the alcohol amine is an organic substance containing an amino group and a hydroxyl group, the molar ratio of the alcohol amine to the silver ion is 1:1 to 10:1, preferably 1.5:1 to 3:1;
- the silver-containing fiber may be selected from the group consisting of silver-containing alginate fibers, silver-containing chitosan fibers, silver-containing acylated chitosan fibers, silver-containing carboxymethyl chitosan fibers, and silver-containing viscous fibers.
- the silver-containing fabric may be selected from the group consisting of silver-containing alginate fabrics, silver-containing chitosan fabrics, silver-containing chitosan fabrics, silver-containing carboxymethyl chitosan fabrics, and silver-containing pastes.
- the silver-containing fabric is a woven, knitted or nonwoven fabric having a basis weight of from 12 to 600 grams per square meter.
- the silver-containing antimicrobial article is a silver-containing polyurethane film or a silver-containing polyurethane sponge having a thickness of 0.1 to 1 mm and a silver-containing polyurethane sponge having a thickness of 1 to 10 mm.
- the silver-containing alginate fiber is a high mannuronic acid type, a high guluronate type or a mannuronic acid/guluronic acid mixed type fiber.
- the silver-containing alginate fiber is calcium alginate fiber or calcium alginate/sodium fiber.
- the silver-containing chitosan fiber has a degree of deacetylation of greater than 80%.
- the silver-containing fibers have a linear density of from 1 to 10 dtex and a fiber length of from 5 to 125 mm.
- the silver-containing antimicrobial article can be obtained by carboxymethylation, carboxyethylation, acylation or sulfonylation modification.
- the silver-containing antimicrobial article is subjected to a slitting, packaging, and sterilization process to form a silver-containing antimicrobial dressing having a silver content of 0.01-10% and a grammage of 12-600. g/m2.
- the silver-containing antimicrobial fabric is processed by a woven, knitted or nonwoven process having a silver content of from 0.01 to 10% and a basis weight of from 12 to 600 grams per square meter.
- the silver-containing antimicrobial fabric is processed from a silver-containing antimicrobial article by a woven, knitted or nonwoven process having a silver content of from 0.01 to 10% and a basis weight of from 12 to 600 grams per square meter.
- the silver-containing antibacterial dressing is prepared by a silver-containing antibacterial fabric by a slitting, packaging and sterilization process, and the silver-containing antibacterial dressing has a silver content of 0.01-10% and a gram weight of 12-600 g. / square meter.
- the invention provides a method of making a silver-containing antimicrobial article.
- the silver-containing antibacterial article is a silver-containing fiber, a silver-containing fabric or a silver-containing polyurethane material, and the method comprises the following steps:
- a silver-containing substance to the alcohol amine to obtain a silver-containing alcohol amine chelate selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or a silver oxalate;
- the alcohol amine is an organic substance containing an amino group and a hydroxyl group, wherein the molar ratio of the alcohol amine to the silver ion is 1:1 to 10:1, preferably 1.5:1 to 3:1;
- step (3) adding the silver-containing alcohol amine chelate to the mixture of the step (1), so that the fiber, fabric or polyurethane material is immersed at 25 to 80 ° C for 1 to 120 minutes, and then taken out and dried to obtain The silver-containing antibacterial article.
- the silver-containing antimicrobial article is a silver-containing fiber, a silver-containing fabric, or a silver-containing polyurethane material
- the method of preparing a silver-containing antimicrobial article includes the following steps:
- step (1) immersing the fiber, fabric or polyurethane material in the alcohol amine solution of step (1);
- a silver-containing substance in a solvent to obtain a silver ion-containing solution or dispersion selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or oxalic acid Silver, the solvent being selected from the group consisting of ethanol, water, or a combination thereof;
- the article wherein the molar ratio of the alkanolamine to the silver ion is from 1:1 to 10:1, preferably from 1.5:1 to 3:1.
- the silver-containing antimicrobial article is a silver-containing fiber
- the method of preparing the silver-containing antimicrobial article is as follows:
- the fiber being selected from the group consisting of alginate fibers, chitosan fibers, viscose fibers, lyocell fibers or sea ray fibers;
- a silver-containing substance to the alcohol amine to obtain a silver-containing alcohol amine chelate selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or Silver oxalate
- the alcohol amine is an organic substance containing an amino group and a hydroxyl group
- the molar ratio of the alcohol amine to the silver ion is 1:1 to 10:1; preferably 1.5:1 to 3:1;
- the spinning obtained silver-containing antimicrobial article is obtained by carboxymethylation, carboxyethylation, acylation or sulfonylation modification.
- the resulting silver-containing alcohol amine chelate can be combined with a specific site of the article by electrostatic action to thereby obtain a silver-containing antimicrobial material containing a silver alcohol amine chelate.
- the fibers used may be staple fibers or filaments, and the filaments may be more advantageous for the impregnation treatment. If filaments are used, they can be cut into staple lengths of 5-125 mm after impregnation for further processing.
- the fabric used includes alginate fabric, chitosan fabric, acylated chitosan fabric, carboxyethyl cellulose fabric, sulfonyl fiber fabric, polypropylene fabric, and rayon fabric. And nylon fabric. These fabrics may be woven, knitted, or nonwoven having a basis weight between 12 and 600 grams per square meter. After the fabric is processed by the method of the present invention, it can be further cut, packaged and sterilized to prepare a silver-containing antibacterial dressing, wherein the silver-containing antibacterial dressing has a silver content of 0.01-10% by weight, including The weight of the silver antibacterial dressing.
- a porous polyurethane material having a thickness of 1 mm or less is generally referred to as a film, and a porous polyurethane material having a thickness of 1 mm or more is referred to as a sponge.
- the polyurethane material used may be a polyurethane film having a thickness of 0.1 to 1 mm or a polyurethane sponge having a thickness of 1 to 10 mm. After the polyurethane material is processed by the method of the invention, it can be further cut, packaged and sterilized to prepare a silver-containing antibacterial dressing, wherein the silver-containing antibacterial polyurethane dressing has a silver content of 0.01-10% by weight.
- the hygroscopic silver-containing antibacterial article is a sol-formed article, such as silver-containing alginate fibers or fabrics, silver-containing carboxymethylcellulose fibers or fabrics, silver-containing Acylated chitosan fibers or fabrics, silver-containing carboxyethyl fibers or fabrics, silver-containing sulfonyl fibers or fabrics, since the sol fibers irreversibly form a gel in aqueous solution, the solvent used should be ethanol and water. Mixture to avoid the formation of an irreversible gel.
- the volume ratio of ethanol to water in the solvent can be greater than 1:1, and the solvent can be used in an amount of more than 30 times the weight of the hygroscopic silver-containing antimicrobial article.
- the hygroscopic silver-containing antibacterial article is a non-solvent article, such as silver-containing rayon fibers or fabrics, silver-containing polypropylene fibers or fabrics, silver-containing lyocell fibers or fabrics, silver-containing viscose fibers or fabrics, Silver-containing non-modified chitosan fiber or fabric and silver-containing polyurethane material, etc., can properly adjust the ratio between water and ethanol in the solution, appropriately increase the proportion of water to reduce the proportion of ethanol, even the solvent can be all from water composition.
- the silver-containing alkamine chelate can be directly added to the fiber spinning solution and spun into a silver-containing fiber by a known spinning process.
- the method is suitable for wet or solvent-spun fibers such as silver-containing alginate fibers, silver-containing chitosan fibers, silver-containing viscose fibers, silver-containing lyocell fibers or silver-containing sea-hair fibers. Since silver-containing alkanolamine chelates are generally very stable, they are very suitable for the preparation of these fibers. In addition, since the spinning solutions of these fibers are generally very viscous, it is advantageous to prevent precipitation and re-agglomeration of the silver-containing chelate compound, so that the silver-containing fibers can be directly woven after being uniformly stirred.
- the silver-containing fiber obtained by the above method can also be prepared into a silver-containing fabric by woven, knitted or non-woven. These silver-containing fabrics can be cut, packaged and sterilized to further form a silver-containing antimicrobial dressing.
- the silver-containing fiber, the silver-containing fabric, the silver-containing polyurethane material or the further silver-containing antimicrobial dressing prepared by the above method of the present invention has a silver content of 0.01 to 10% by weight, and comprises a silver fiber or a silver-containing fabric or a silver-containing polyurethane.
- the weight of the material or silver-containing antibacterial dressing is 12-600 g/m2.
- the non-solifying fibers or fabrics produced by the process of the present invention can be further chemically modified to increase their moisture absorption properties or gel forming properties.
- viscose fibers can be carboxymethylated, carboxyethylated or sulfonylated to give carboxymethylated cellulose, carboxyethylated cellulose, and sulfonyl cellulose; chitosan is carboxymethylated or Acylation can respectively give carboxymethylated chitosan or acylated chitosan.
- the sterilization method of the present invention includes cobalt 60 irradiation, ethylene oxide, electron beam, high temperature and the like.
- the hygroscopicity of the articles of the present invention was tested using the method of BS: EN13726-1-2002, and the amount of silver contained was tested by an atomic absorption spectrophotometer.
- the hygroscopicity of the silver-containing antimicrobial articles (fiber, fabric or polyurethane materials) and silver-containing antimicrobial dressings referred to in the present invention are represented by two methods: g/g and g/100 cm 2 . These two representations can be linked by the weight of the fabric or dressing.
- a silver-containing chitosan dressing has a hygroscopicity of 23 g/g and a dressing weight of 130 gsm (g/m 2 ).
- the silver-containing alcohol amine chelate of the invention has a broad antibacterial spectrum as an antibacterial component, and exhibits strong antibacterial activity against gram-negative bacteria and gram-positive bacteria, and has a rapid effect and It has light stability and can be widely used in chronic infectious exudative wounds, such as diabetic foot, acne and some cave-type wounds, providing a moist environment and an anti-infective barrier for wound healing.
- Figure 1 shows the zone of inhibition of the dressing containing 0.5% by weight of silver ions prepared in Example 22 after 1 day in a S. aureus culture dish.
- Figure 2 shows the zone of inhibition of the dressing containing 0.55% by weight of silver ions prepared in Example 23 after 3 days in a S. aureus culture dish.
- Figure 3 shows the zone of inhibition of the dressing containing 0.79 wt% silver ion prepared in Example 24 after 1 day in a S. aureus culture dish.
- Figure 4 shows the zone of inhibition of the dressing containing 0.3% by weight of silver ions prepared in Example 26 after 3 days in a S. aureus culture dish.
- Figure 5 shows the zone of inhibition of the dressing containing 0.8% by weight of silver ions prepared in Example 28 after 1 day in a S. aureus culture dish.
- Figure 6 shows the zone of inhibition of the dressing containing 0.93% by weight of silver ions prepared in Example 33 after 3 days in a S. aureus culture dish.
- Figure 7 shows the zone of inhibition of the dressing containing 0.83 wt% silver ions prepared in Example 36 after 1 day in a S. aureus culture dish.
- Figure 8 shows the zone of inhibition of the dressing containing 2.8% by weight of silver ions prepared in Example 39 after 3 days in a S. aureus culture dish.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the above preparation process is carried out at normal temperature.
- the silver-containing carboxymethyl modified cellulose dressing has a basis weight of 120 g/m 2 (gsm), a hygroscopicity of 22 g/g, and a silver content of 0.2%, based on the weight of the silver-containing dressing.
- the pH of the silver-containing modified cellulose dressing is from 6.1 to 6.2.
- the acylated chitosan fiber was immersed in 2500 ml of absolute alcohol at room temperature to sufficiently wet it, and then the silver-containing alcohol amine chelate solution prepared in Example 2 was added to the above mixture to make an acyl group.
- the chitosan fiber is fully soaked in a solution at 40 ° C, taken out, squeezed and dried, and then subjected to a conventional nonwoven process, and cut, packaged and sterilized to obtain a silver-containing chitosan dressing.
- the silver-containing chitosan dressing has a basis weight of 120 gsm and a hygroscopicity of 20 g/100 cm 2 and a silver content of 0.5% by weight of the dressing.
- the pH of the dressing is 6.8-7.1.
- the inhibition zone of the dressing of this example after 1 day in the S. aureus culture dish is shown in Figure 1, which indicates that the wound dressing of the silver-containing alkamine chelate has a certain bacteriostatic effect on S. aureus.
- the silver-containing viscose fiber dressing had a basis weight of 110 gsm and a hygroscopicity of 12 g/100 cm 2 and a silver content of 0.55% by weight based on the weight of the dressing.
- the dressing has a pH of 4.3-6.8.
- the inhibition zone of the dressing of this example after 3 days in the S. aureus culture dish is shown in Figure 2, which indicates that the wound dressing of the silver-containing alcohol amine chelate has a certain bacteriostatic effect on Staphylococcus aureus.
- the silver-containing acylated chitosan dressing had a hygroscopicity of 20 g/100 cm 2 and a silver content of 0.79 wt% based on the weight of the dressing.
- the pH of the dressing is 6.8-7.0.
- the inhibition zone of the dressing of this example after 1 day in the S. aureus culture dish is shown in Figure 3, which indicates that the wound dressing of the silver-containing alkamine chelate has a certain bacteriostatic effect on S. aureus.
- viscose fabric 100 g was immersed in 2500 ml of pure water at room temperature to sufficiently wet it, and then the alcohol amine chelate solution prepared in Example 10 was added to the above mixture to make it sticky.
- the rubber fiber fabric was fully immersed in the solution at 60 ° C for 120 minutes, taken out, squeezed and dried, and then cut, packaged and sterilized to obtain a silver-containing viscose fiber dressing having a basis weight of 80 gsm.
- the silver-containing viscose fiber dressing had a hygroscopicity of 10 g/100 cm 2 and a silver content of 1.5% by weight based on the weight of the dressing.
- the pH of the dressing is 5.0-7.0.
- a polyurethane film 100 g was immersed in 2500 ml of absolute alcohol at room temperature to sufficiently wet it, and then the silver-containing alcohol amine chelate solution prepared in Example 12 was added to the above mixture.
- the polyurethane film was sufficiently immersed in the solution at 60 ° C for 90 minutes, taken out, squeezed and dried, and then cut, packaged and sterilized to obtain a silver-containing polyurethane film dressing.
- the silver-containing polyurethane film dressing had a hygroscopicity of 6 g/100 cm 2 and a silver content of 0.3% by weight based on the weight of the dressing.
- the inhibition zone of the dressing of this example after 3 days in the S. aureus culture dish is shown in Figure 4, which indicates that the wound dressing of the silver-containing alkamine chelate has a certain bacteriostatic effect on Staphylococcus aureus.
- carboxymethyl modified cellulose fiber 100 g was immersed in 2500 ml of absolute alcohol at room temperature to sufficiently wet it, and then the silver-containing alcohol amine chelate solution prepared in Example 15 was added to the above mixture.
- the carboxymethyl modified cellulose fiber is fully soaked in the solution at room temperature for 35 minutes, taken out, squeezed and dried, and then subjected to a conventional nonwoven process, and cut, packaged and sterilized to obtain a silver-containing modification.
- the silver-containing carboxymethyl modified cellulose dressing had a basis weight of 126 g/100 cm 2 , a hygroscopicity of 24 g/g, and a silver content of 0.4%, based on the weight of the silver-containing dressing.
- the pH of the silver-containing modified cellulose dressing is from 6.1 to 6.2.
- the above operations were all carried out at room temperature.
- the fiber was taken out, squeezed and dried to obtain a silver-containing carboxymethyl modified cellulose fiber having a hygroscopicity of 18 g/g and a silver content of 0.8% by weight.
- the fiber is taken out, squeezed and dried, and then subjected to a conventional nonwoven process, and cut, packaged, and sterilized to obtain a silver-containing chitosan dressing.
- the silver-containing acylated chitosan dressing had a basis weight of 135 gsm and a hygroscopicity of 22 g/100 cm 2 and a silver content of 0.6% by weight based on the weight of the dressing.
- the dressing has a pH of 6.5.
- the fiber is taken out, squeezed and dried, and then subjected to a conventional nonwoven fabric process, and cut, packaged and sterilized to obtain a silver-containing viscose fiber dressing.
- the silver-containing viscose fiber dressing had a basis weight of 100 gsm and a hygroscopicity of 16 g/100 cm 2 and a silver content of 0.7% by weight based on the weight of the dressing.
- the dressing has a pH of 5.5.
- the above operations were all carried out at 45 °C.
- the fiber was taken out, squeezed and dried to obtain a silver-containing carboxymethyl modified cellulose fiber having a hygroscopicity of 17 g/g and a silver content of 0.9% by weight.
- the fiber is taken out, squeezed and dried, and then subjected to a conventional nonwoven process, and cut, packaged, and sterilized to obtain a silver-containing viscose fiber dressing.
- the silver-containing viscose fiber dressing had a basis weight of 110 gsm and a hygroscopicity of 18 g/gsm and a silver content of 0.93 wt% based on the weight of the dressing.
- the pH of the dressing is 5.
- the inhibition zone of the dressing of this example after 3 days in the S. aureus culture dish is shown in Figure 6, which indicates that the wound dressing of the silver-containing alkamine chelate has a certain bacteriostatic effect on Staphylococcus aureus.
- the above operations were all carried out at room temperature.
- the above fabric was taken out, squeezed and dried, and then cut, packaged and sterilized to obtain a silver-containing carboxymethyl modified cellulose dressing having a basis weight of 130 gsm.
- the silver-containing carboxymethyl modified cellulose dressing had a hygroscopicity of 21 g/100 cm 2 and a silver content of 0.7% by weight based on the weight of the dressing.
- the dressing has a pH of 6.3.
- the above operations were all carried out at 50 °C.
- the above fabric was taken out, squeezed and dried, and after cutting, packaging and sterilization, a silver-containing chitosan dressing was obtained, and the basis weight was 140 gsm.
- the silver-containing acylated chitosan dressing had a hygroscopicity of 26 g/100 cm 2 , a silver content of 0.6% by weight based on the weight of the dressing, and a dressing pH of 6.8.
- the above operations were all carried out at 65 °C.
- the above fabric was taken out, squeezed and dried, and after cutting, packaging and sterilization, a silver-containing viscose fiber dressing was obtained, and the basis weight was 100 gsm.
- the silver-containing viscose fiber dressing had a hygroscopicity of 12 g/100 cm 2 and a silver content of 0.83 wt% based on the weight of the dressing.
- the dressing has a pH of 6.8.
- the inhibition zone of the dressing of this example after 1 day in the S. aureus culture dish is shown in Figure 7, which indicates that the wound dressing of the silver-containing alcohol amine chelate has a certain bacteriostatic effect on Staphylococcus aureus.
- the above operations were all carried out at 60 °C.
- the above-mentioned fabric is taken out, squeezed and dried, and after being cut, packaged and sterilized, a silver-containing polyurethane film dressing is obtained.
- the silver-containing polyurethane film dressing had a hygroscopicity of 8 g/100 cm 2 and a silver content of 0.6% by weight based on the weight of the dressing.
- the above operations were all carried out at 60 °C.
- the above fabric is taken out, squeezed and dried, and after being cut, packaged and sterilized, a silver-containing polyurethane foam dressing is obtained.
- the silver-containing polyurethane foam dressing had a hygroscopicity of 26 g/100 cm 2 and a silver content of 0.6% by weight based on the weight of the dressing.
- a calcium alginate fiber having an antibacterial component of a silver-containing alcohol amine chelate compound having a fiber linear density of 3 dtex and a length of 75 mm can be obtained.
- the silver-containing alginate fabric can be obtained, and then the calcium alginate silver-containing dressing can be obtained after slitting, packaging and sterilization.
- the dressing weight is 180gsm, the hygroscopicity is 40g/g, and the weight of the dressing is included. The amount of silver was 2.8% by weight.
- the dressing has a pH of 6.6.
- the inhibition zone of the dressing of this example after 3 days in the S. aureus culture dish is shown in Fig. 8, which indicates that the wound dressing of the silver-containing alkamine chelate has a certain bacteriostatic action against Staphylococcus aureus.
- chitosan powder 100 g is added to an appropriate amount of 2% acetic acid solution and stirred well, a suitable spinning solution is obtained according to a conventional method, and then the silver-containing alcohol amine chelate prepared according to Example 6 is added to the spinning solution at room temperature. The solution is fully stirred to make it evenly dispersed in the spinning solution, and the obtained silver-containing spinning solution is extruded to a spinneret through a metering pump, and then sequentially passed through a coagulation bath, hot water drawing, washing, drying, and drying.
- a chitosan fiber containing an antibacterial component of a silver-containing alcohol amine chelate compound having a fiber fineness of 2 dtex and a length of 60 mm can be obtained.
- the silver-containing fabric can be obtained through a conventional nonwoven process.
- a chitosan-containing silver dressing can be obtained. According to the weight of the dressing, the silver content is 1.05%, the dressing weight is 120gsm, and the dressing moisture absorption is 14g. /100cm 2 .
- the pH of the dressing was 7.2.
- the silver-containing alcohol amine chelate solution prepared according to Example 8 Adding the silver-containing alcohol amine chelate solution prepared according to Example 8 to the conventional viscose fiber spinning solution (solid content 9%) at room temperature, stirring well to disperse evenly in the spinning solution, and then The obtained silver-containing spinning solution is extruded to a spinneret through a metering pump, and then passes through a coagulation bath, a hot water drawing, washing, drying and cutting process to obtain a viscose fiber containing an antibacterial component of an alcohol amine chelate.
- the fiber fineness is 3dtex and the length is 50mm.
- the silver-containing viscose fiber can obtain a silver-containing fabric through a conventional nonwoven process.
- a viscose fiber-containing silver dressing After slitting, packaging and sterilization, a viscose fiber-containing silver dressing can be obtained, and the basis weight is 120 gsm.
- the silver content is based on the weight of the dressing. 3.06%, the dressing moisture absorption is 10g/100cm 2 .
- the pH of the dressing was 5.6.
- the silver-containing chitosan fiber obtained in Example 40 is acylated or carboxymethylated with succinic anhydride or sodium chloroacetate to obtain an acylated chitosan or a carboxymethylated chitosan fiber.
- the fineness is 2.1 dtex and the length is 60 mm.
- the silver-containing fabric can be obtained through a conventional nonwoven process, and the modified chitosan silver-containing dressing can be obtained after slitting, packaging and sterilization.
- the silver-containing modified chitosan dressing had a basis weight of 125 gsm and a hygroscopicity of 22 g/100 cm 2 and a silver content of 0.9% by weight based on the weight of the dressing.
- the dressing has a pH of 7.
- the silver-containing viscose fiber obtained in Example 41 was subjected to carboxymethylation reaction with sodium chloroacetate to obtain a carboxymethylated cellulose fiber having a fiber fineness of 3.3 dtex and a length of 50 mm, which was passed through a conventional nonwoven fabric.
- the process can obtain a silver-containing fabric, and the modified cellulose fiber silver-containing dressing can be obtained after slitting, packaging and sterilization.
- the modified cellulose silver-containing dressing has a basis weight of 123 gsm and a hygroscopicity of 26 g/100 cm 2 and a silver content of 2.5% by weight of the dressing.
- the dressing has a pH of 6.5.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本发明涉及一种含银抗菌制品及其制备方法,尤其是涉及一种含有含银的醇胺螯合物的含银制品。所述制品可以用于医用敷料和其他抗菌领域。The invention relates to a silver-containing antibacterial product and a preparation method thereof, in particular to a silver-containing product containing a silver-containing alcohol amine chelate compound. The articles can be used in medical dressings and other antimicrobial fields.
随着人们生活水平的提高和饮食习惯的变化,人类的疾病谱呈现出一些新的特点。由糖尿病、压疮、褥疮和高血压等疾病引发的静脉性溃疡、动脉性溃疡、糖尿病性溃疡、创伤性溃疡、压力性溃疡等慢性渗出性伤口严重影响着人们的身体健康。渗出性伤口是一类会分泌大量渗出液的慢性伤口,而渗出液的主要成分是一些脓液、组织液和一些坏死的组织和细胞。因此,慢性渗出性伤口的护理除了应该充分吸收伤口渗出液,为伤口愈合提供温暖和湿润的愈合环境,还应该及时对伤口进行抗感染护理。With the improvement of people's living standards and changes in eating habits, human disease spectrum presents some new features. Chronic exudative wounds such as venous ulcers, arterial ulcers, diabetic ulcers, traumatic ulcers, and pressure ulcers caused by diseases such as diabetes, pressure sores, hemorrhoids, and hypertension seriously affect people's health. Exudative wounds are a type of chronic wound that secretes large amounts of exudate, while the main components of exudates are pus, tissue fluid, and some necrotic tissues and cells. Therefore, the care of chronic exudative wounds should not only fully absorb the wound exudate, but also provide a warm and moist healing environment for wound healing. Anti-infective care should also be carried out on the wound in time.
目前,市场上应用在敷料中的抗菌性含银物质主要是一些银的有机盐和无机盐,例如硝酸银、氯化银、次氯酸银、碳酸银、醋酸银、磷酸锆钠银等等。At present, the antibacterial silver-containing substances used in the dressings on the market are mainly some organic and inorganic salts of silver, such as silver nitrate, silver chloride, silver hypochlorite, silver carbonate, silver acetate, sodium zirconium phosphate, etc. .
美国专利US6,897,349和欧洲专利EP1216065公开了制备含银抗菌材料的方法,该方法通过在制备纤维过程中,使氯化银分散于纤维之中。但这种伤口敷料的生产过程中材料(氯)对设备的腐蚀性很大。U.S. Patent No. 6,897,349 and European Patent No. 1,216,065 disclose the preparation of a silver-containing antibacterial material by dispersing silver chloride in the fibers during the preparation of the fibers. However, the material (chlorine) in the production of such wound dressings is highly corrosive to equipment.
中国专利CN1308509C公开了一种具有抗菌作用的含银甲壳胺纤维及其制备方法,该方法将粒径为1微米左右的银化合物颗粒,即银磷酸锆氢钠(商品名为Alphasan)混合于纺丝溶液中,该银化合物含银量为3.0-4.0重量%。由于Alphasan本身含银量有限,因此产品的含银量也很小。此外Alphasan的粒径太大,对纤维强度不利。Chinese patent CN1308509C discloses a silver-containing chitosan fiber having antibacterial action and a preparation method thereof, which comprises mixing silver compound particles having a particle diameter of about 1 micrometer, that is, sodium zirconium hydrogen phosphate (trade name: Alphasan) in spinning. In the silk solution, the silver compound contains silver in an amount of from 3.0 to 4.0% by weight. Because Alphasan itself has a limited amount of silver, the silver content of the product is also small. In addition, the particle size of Alphasan is too large, which is detrimental to fiber strength.
离子型抗菌敷料对银的使用效率较高,市场上主要含银抗菌敷料大都是离子型的。但是目前离子型含银敷料使用的银化合物大都是水溶性很低的,如氯化银、碳酸银等,由于它们在水中的溶解度低,遇 水后仅电离出少量的银离子便达到平衡,当这些少量的银离子被消耗后,不溶的银化合物才重新电离出少量的银离子,通过这样的溶解平衡达到持续释放银离子的效果。使用水溶性低的离子型含银敷料虽然可以持续地释放银离子,但其遇水后银离子释放量较少,因此仍然需要相对较多的银化合物才能实现需要的抗菌效果。此外,这种类型的伤口敷料银释放表现一般,以1%的含银量计算,在10ml伤口模拟液中24小时的银释放量只有20ppm左右,这在一定程度上影响了其抗菌效果和作用时间,除此之外,大多数的离子型含银敷料不太稳定,放置一段时间后含银敷料会变色,影响了其作为商品的外观可接受性。Ionic antibacterial dressings have a high efficiency in the use of silver, and most of the silver-containing antibacterial dressings on the market are mostly ionic. However, most of the silver compounds used in ionic silver-containing dressings are very low in water solubility, such as silver chloride, silver carbonate, etc., because of their low solubility in water, only a small amount of silver ions are ionized after water to reach equilibrium. When these small amounts of silver ions are consumed, the insoluble silver compound re-ionizes a small amount of silver ions, and the effect of sustained release of silver ions is achieved by such a dissolution balance. The use of a low-water-soluble ionic silver-containing dressing can release silver ions continuously, but it releases less silver ions after water contact, so relatively more silver compounds are still needed to achieve the desired antibacterial effect. In addition, the release of silver in this type of wound dressing is generally performed. The amount of silver released in 10 ml of wound simulating solution is only about 20 ppm in 10 ml of wound simulant, which affects its antibacterial effect and effect to some extent. Time, in addition, most of the ionic silver-containing dressings are not stable, and the silver-containing dressings will change color after being left for a period of time, affecting their acceptability as a commercial appearance.
此外,目前有研究使用了含银配合物作为抗菌剂,如硫代硫酸银配合物和银氨配合物,但这类含银配合物是一类无机螯合物,在水中的溶解性好,而在乙醇等有机溶剂中的溶解性较差,这对遇水会成胶的制品是相当不利的,如羧甲基纤维素纤维制品、羧乙基纤维素纤维制品和酰化壳聚糖纤维制品。In addition, studies have used silver-containing complexes as antibacterial agents, such as silver thiosulfate complexes and silver-ammonia complexes, but such silver-containing complexes are a class of inorganic chelate compounds that have good solubility in water. However, the solubility in organic solvents such as ethanol is poor, which is quite disadvantageous for products which are gelled by water, such as carboxymethyl cellulose fiber products, carboxyethyl cellulose fiber products, and acylated chitosan fibers. product.
发明内容Summary of the invention
为了解决上述问题,在一方面,本发明公开了一种含银抗菌制品,所述含银抗菌制品包含含银的醇胺螯合物作为抗菌成分,所述含银的醇胺螯合物均匀分布并结合于制品的内部和/或表面,以制品重量计,所述制品的含银量为0.01-10重量%,且所述制品的吸湿能力为6g/g以上。In order to solve the above problems, in one aspect, the present invention discloses a silver-containing antibacterial article comprising a silver-containing alcohol amine chelate as an antibacterial component, and the silver-containing alcohol amine chelate compound is uniform. Distributing and incorporating to the interior and/or surface of the article, the article has a silver content of from 0.01 to 10% by weight, based on the weight of the article, and the article has a moisture absorption capacity of 6 g/g or more.
本发明所述的含银的醇胺螯合物根据醇胺碳原子链的长度有不同的同分异构体,所述醇胺是一种含有氨基和羟基的有机物,例如,不同碳链长度的含银的醇胺螯合物的结构如下所示:The silver-containing alcohol amine chelate of the present invention has different isomers according to the length of the alcohol amine carbon atom chain, and the alcohol amine is an organic substance containing an amino group and a hydroxyl group, for example, different carbon chain lengths. The structure of the silver-containing alcohol amine chelate is as follows:
依此类推,包括一系列不同碳链长度的同分异构体。含银的醇胺螯合物是一类稳定的以银为中心的螯合物,银离子与醇胺分子以1:2 的形式螯合,从而形成可溶性的螯合物。在制备时,既可将醇胺逐渐滴加至含银化合物的分散体中,又可将含银化合物的分散体滴加至醇胺中,直至得到均一的含银的醇胺螯合物溶液,所述含银化合物的分散体是指沉淀、胶体或者溶液。如果以可溶性含银化合物(如硝酸银)为原料,最好应先将其转化为微溶、难溶或不溶的含银化合物,然后与醇胺充分混合反应,直至沉淀刚好溶解。And so on, including a series of isomers of different carbon chain lengths. The silver-containing alkamine chelate is a stable silver-centered chelate, and the silver ion and the alkanolamine molecule are chelated in a 1:2 form to form a soluble chelate. In the preparation, the alcohol amine can be gradually added dropwise to the dispersion of the silver-containing compound, and the dispersion of the silver-containing compound can be added dropwise to the alcohol amine until a uniform silver-containing alcohol amine chelate solution is obtained. The dispersion of the silver-containing compound means a precipitate, a colloid or a solution. If a soluble silver-containing compound (such as silver nitrate) is used as the starting material, it should preferably be converted into a slightly soluble, poorly soluble or insoluble silver-containing compound, and then thoroughly mixed with the alcohol amine until the precipitate just dissolves.
本发明含银的醇胺螯合物通过将含银物质与醇胺充分混合反应而得到,其中醇胺与银离子的摩尔比为1:1~10:1,优选为1.5:1~3:1,所述含银物质选自硝酸银、硫酸银、氯化银、氧化银、醋酸银或草酸银,所述醇胺是一种含有氨基和羟基的有机物。The silver-containing alcohol amine chelate of the present invention is obtained by thoroughly mixing a silver-containing substance with an alcohol amine, wherein the molar ratio of the alcohol amine to the silver ion is 1:1 to 10:1, preferably 1.5:1 to 3: 1. The silver-containing material is selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver acetate or silver oxalate, and the alcohol amine is an organic substance containing an amino group and a hydroxyl group.
以可溶性的硝酸银为例,硝酸银先与适当过量的氢氧化钠反应生成难溶的氧化银沉淀,然后向其中逐渐滴加乙醇胺,直至所生成的氧化银沉淀刚好溶解,从而得到澄清透明的含银的乙醇胺螯合物溶液。Taking soluble silver nitrate as an example, silver nitrate is first reacted with an appropriate excess of sodium hydroxide to form a poorly soluble silver oxide precipitate, and then ethanolamine is gradually added dropwise until the formed silver oxide precipitate just dissolves, thereby obtaining a clear and transparent Silver-containing ethanolamine chelate solution.
AgNO 3+NaOH->Ag 2O+NaNO 3+H 2O AgNO 3 +NaOH->Ag 2 O+NaNO 3 +H 2 O
以不可溶的乙酸银与乙醇胺为例,反应后得到可溶的含银的乙醇胺螯合物。Taking insoluble silver acetate and ethanolamine as an example, a soluble silver-containing ethanolamine chelate is obtained after the reaction.
在一个实施方案中,本发明的含银抗菌制品为含银纤维、含银织 物、或含银聚氨酯材料,其可按如下方法制得:In one embodiment, the silver-containing antimicrobial article of the present invention is a silver-containing fiber, a silver-containing fabric, or a silver-containing polyurethane material, which can be obtained as follows:
(1)将纤维、织物或聚氨酯材料浸渍在溶剂中,所述溶剂选自乙醇、水或它们的组合;(1) immersing the fiber, fabric or polyurethane material in a solvent selected from the group consisting of ethanol, water or a combination thereof;
(2)将含银物质添加至醇胺中,从而获得含银的醇胺螯合物,所述含银物质选自硝酸银、硫酸银、氯化银、氧化银、碳酸银、乙酸银或草酸银;所述醇胺是一种含有氨基和羟基的有机物,其中醇胺与银离子的摩尔比为1:1~10:1,优选为1.5:1~3:1;(2) adding a silver-containing substance to the alcohol amine to obtain a silver-containing alcohol amine chelate, the silver-containing substance being selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or a silver oxalate; the alcohol amine is an organic substance containing an amino group and a hydroxyl group, wherein the molar ratio of the alcohol amine to the silver ion is 1:1 to 10:1, preferably 1.5:1 to 3:1;
(3)将所述含银的醇胺螯合物添加至步骤(1)的混合物中,使得纤维、织物或聚氨酯材料在25-80℃浸渍1-120分钟,然后取出烘干,从而获得所述含银抗菌制品。(3) adding the silver-containing alcohol amine chelate to the mixture of the step (1), so that the fiber, fabric or polyurethane material is immersed at 25-80 ° C for 1-120 minutes, and then taken out and dried to obtain a A silver-containing antibacterial product is described.
在一个实施方案中,本发明的含银抗菌制品为含银纤维、含银织物或含银聚氨酯材料,其可按如下方法制得:In one embodiment, the silver-containing antimicrobial article of the present invention is a silver-containing fiber, a silver-containing fabric, or a silver-containing polyurethane material, which can be prepared as follows:
(1)将醇胺溶解于溶剂中,所述醇胺是一种含有氨基和羟基的有机物,所述溶剂选自乙醇、水或它们的组合;(1) dissolving an alcohol amine in a solvent, the alcohol amine being an organic substance containing an amino group and a hydroxyl group, the solvent being selected from the group consisting of ethanol, water, or a combination thereof;
(2)将纤维、织物或聚氨酯材料浸渍于步骤(1)的醇胺溶液中;(2) immersing the fiber, fabric or polyurethane material in the alcohol amine solution of step (1);
(3)将含银物质分散于溶剂中,从而获得含银离子的溶液或分散体,所述含银物质选自硝酸银、硫酸银、氯化银、氧化银、碳酸银、醋酸银或草酸银,所述溶剂选自乙醇、水或它们的组合;(3) dispersing a silver-containing substance in a solvent to obtain a silver ion-containing solution or dispersion selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or oxalic acid Silver, the solvent being selected from the group consisting of ethanol, water, or a combination thereof;
(4)在25-80℃下将所述含银离子的溶液或分散体添加至步骤(2)的混合物中,并静置1-120分钟,然后取出烘干,从而获得所述含银抗菌制品,其中醇胺与银离子的摩尔比为1:1~10:1,优选为1.5:1~3:1。(4) adding the silver ion-containing solution or dispersion to the mixture of the step (2) at 25-80 ° C, and allowing to stand for 1-120 minutes, and then taking out and drying to obtain the silver-containing antibacterial agent. The article wherein the molar ratio of the alkanolamine to the silver ion is from 1:1 to 10:1, preferably from 1.5:1 to 3:1.
在另一个实施方案中,本发明所述的含银抗菌制品为含银纤维、含银织物或含银聚氨酯材料,其可按如下方法制得:In another embodiment, the silver-containing antimicrobial article of the present invention is a silver-containing fiber, a silver-containing fabric, or a silver-containing polyurethane material, which can be obtained as follows:
(1)将含银物质分散于溶剂中,从而获得含有银离子的溶液或分散体,所述含银物质选自硝酸银、硫酸银、氯化银、氧化银、碳酸银、醋酸银或草酸银,所述溶剂选自乙醇、水或它们的组合;(1) dispersing a silver-containing substance in a solvent to obtain a solution or dispersion containing silver ions selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or oxalic acid Silver, the solvent being selected from the group consisting of ethanol, water, or a combination thereof;
(2)将纤维、织物或聚氨酯材料浸渍于所述含银离子的溶液或分散体中;(2) immersing a fiber, fabric or polyurethane material in the silver ion-containing solution or dispersion;
(3)将醇胺溶解于溶剂中,所述溶剂选自乙醇、水或它们的组合,所述醇胺是一种含有氨基和羟基的有机物;(3) dissolving an alcohol amine in a solvent selected from the group consisting of ethanol, water, or a combination thereof, the alcohol amine being an organic substance containing an amino group and a hydroxyl group;
(4)在25-80℃下将步骤(3)醇胺溶液添加至步骤(2)的混合 物中,并静置1-120分钟,然后取出烘干,从而获得所述含银抗菌制品,其中醇胺与银离子的摩尔比为1:1~10:1,优选为1.5:1~3:1。(4) adding the step (3) alkanolamine solution to the mixture of the step (2) at 25-80 ° C, and allowing to stand for 1-120 minutes, and then taking out and drying to obtain the silver-containing antibacterial article, wherein The molar ratio of the alkanolamine to the silver ion is from 1:1 to 10:1, preferably from 1.5:1 to 3:1.
在又一个实施方案中,本发明所述的含银抗菌制品为含银纤维,其可按如下方法制得:In yet another embodiment, the silver-containing antimicrobial article of the present invention is a silver-containing fiber which can be prepared as follows:
(1)按照常规湿法纺丝方法制备纤维纺丝液,所述纤维选自海藻酸盐纤维、壳聚糖纤维、粘胶纤维、莱赛尔纤维或海丝纤维;(1) preparing a fiber spinning solution according to a conventional wet spinning method, the fiber being selected from the group consisting of alginate fibers, chitosan fibers, viscose fibers, lyocell fibers or sea ray fibers;
(2)将含银物质添加至醇胺中,从而获得含银的醇胺螯合物,所述含银物质选自硝酸银、硫酸银、氯化银、氧化银、碳酸银、醋酸银或草酸银,所述醇胺是一种含有氨基和羟基的有机物,醇胺与银离子的摩尔比为1:1~10:1,优选为1.5:1~3:1;(2) adding a silver-containing substance to the alcohol amine to obtain a silver-containing alcohol amine chelate selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or Silver oxalate, the alcohol amine is an organic substance containing an amino group and a hydroxyl group, the molar ratio of the alcohol amine to the silver ion is 1:1 to 10:1, preferably 1.5:1 to 3:1;
(3)将所述含银的醇胺螯合物添加至所述纺丝液,并搅拌均匀,从而得到含银纺丝液;(3) adding the silver-containing alcohol amine chelate to the spinning solution, and stirring uniformly to obtain a silver-containing spinning solution;
(4)使用所述含银纺丝液纺丝并烘干,从而得到所述含银抗菌制品。(4) Spinning and drying using the silver-containing spinning solution to obtain the silver-containing antibacterial article.
在一个实施方案中,所述含银纤维可选自含银海藻酸盐纤维、含银壳聚糖纤维、含银酰化壳聚糖纤维、含银羧甲基壳聚糖纤维、含银粘胶纤维、含银银莱赛尔纤维、含银海丝纤维、含银羧甲基纤维素纤维、含银羧乙基纤维素纤维、含银磺酰基纤维、含银丙纶纤维、含银绦纶纤维或含银尼纶纤维。在一个实施方案中,所述含银织物可选自含银海藻酸盐织物、含银壳聚糖织物、含银酰化壳聚糖织物、含银羧甲基壳聚糖织物、含银粘胶纤维织物、含银莱赛尔织物、含银海丝纤维织物、含银羧甲基纤维素织物、含银羧乙基纤维素织物、含银磺酰基纤维织物、含银丙纶织物、含银绦纶织物或含银尼纶纤维织物。In one embodiment, the silver-containing fiber may be selected from the group consisting of silver-containing alginate fibers, silver-containing chitosan fibers, silver-containing acylated chitosan fibers, silver-containing carboxymethyl chitosan fibers, and silver-containing viscous fibers. Glue fiber, silver-containing lyocell fiber, silver-containing sea silk fiber, silver-containing carboxymethyl cellulose fiber, silver-containing carboxyethyl cellulose fiber, silver-containing sulfonyl fiber, silver-containing polypropylene fiber, silver-containing rayon Fiber or silver-containing nylon fiber. In one embodiment, the silver-containing fabric may be selected from the group consisting of silver-containing alginate fabrics, silver-containing chitosan fabrics, silver-containing chitosan fabrics, silver-containing carboxymethyl chitosan fabrics, and silver-containing pastes. Glue fiber fabric, silver-containing lyocell fabric, silver-containing seaweed fiber fabric, silver-containing carboxymethyl cellulose fabric, silver-containing carboxyethyl cellulose fabric, silver-containing sulfonyl fiber fabric, silver-containing polypropylene fabric, silver-containing Polyester fabric or silver-containing nylon fabric.
在一个实施方案中,所述含银织物为机织物、针织物或非织造物,所述含银织物的克重为12-600克/平方米。In one embodiment, the silver-containing fabric is a woven, knitted or nonwoven fabric having a basis weight of from 12 to 600 grams per square meter.
在一个实施方案中,所述含银抗菌制品为含银聚氨酯薄膜或者含银聚氨酯海绵,含银聚氨酯薄膜厚度为0.1-1毫米,含银聚氨酯海绵厚度为1-10毫米。In one embodiment, the silver-containing antimicrobial article is a silver-containing polyurethane film or a silver-containing polyurethane sponge having a thickness of 0.1 to 1 mm and a silver-containing polyurethane sponge having a thickness of 1 to 10 mm.
在一个实施方案中,所述含银海藻酸盐纤维为高甘露醛酸型、高古洛糖醛酸型或甘露醛酸/古洛糖醛酸混合型纤维。In one embodiment, the silver-containing alginate fiber is a high mannuronic acid type, a high guluronate type or a mannuronic acid/guluronic acid mixed type fiber.
在一个实施方案中,所述含银海藻酸盐纤维为海藻酸钙纤维或海 藻酸钙/钠纤维。In one embodiment, the silver-containing alginate fiber is calcium alginate fiber or calcium alginate/sodium fiber.
在一个实施方案中,所述含银壳聚糖纤维的脱乙酰度在80%以上。In one embodiment, the silver-containing chitosan fiber has a degree of deacetylation of greater than 80%.
在一个实施方案中,所述含银纤维的线密度为1-10dtex,纤维长度为5-125mm。In one embodiment, the silver-containing fibers have a linear density of from 1 to 10 dtex and a fiber length of from 5 to 125 mm.
在一个实施方案中,所述含银抗菌制品可以进行羧甲基化、羧乙基化、酰化或者磺酰基化改性而得到。In one embodiment, the silver-containing antimicrobial article can be obtained by carboxymethylation, carboxyethylation, acylation or sulfonylation modification.
在一个实施方案中,所述含银抗菌制品经过分切、包装和灭菌工艺制成含银抗菌敷料,所述含银抗菌敷料的含银量为0.01-10%,克重为12-600克/平方米。In one embodiment, the silver-containing antimicrobial article is subjected to a slitting, packaging, and sterilization process to form a silver-containing antimicrobial dressing having a silver content of 0.01-10% and a grammage of 12-600. g/m2.
在一个实施方案中,所述含银抗菌织物是经过机织、针织或者非织造工艺加工制得,含银量为0.01-10%,克重为12-600克/平方米。In one embodiment, the silver-containing antimicrobial fabric is processed by a woven, knitted or nonwoven process having a silver content of from 0.01 to 10% and a basis weight of from 12 to 600 grams per square meter.
在一个实施方案中,所述含银抗菌织物由含银抗菌制品经过机织、针织或者非织造工艺加工而成,含银量为0.01-10%,克重为12-600克/平方米。In one embodiment, the silver-containing antimicrobial fabric is processed from a silver-containing antimicrobial article by a woven, knitted or nonwoven process having a silver content of from 0.01 to 10% and a basis weight of from 12 to 600 grams per square meter.
在一个实施方案中,所述含银抗菌敷料由含银抗菌织物经分切、包装和灭菌工艺制得,含银抗菌敷料的含银量为0.01-10%,克重为12-600克/平方米。In one embodiment, the silver-containing antibacterial dressing is prepared by a silver-containing antibacterial fabric by a slitting, packaging and sterilization process, and the silver-containing antibacterial dressing has a silver content of 0.01-10% and a gram weight of 12-600 g. / square meter.
在另一方面,本发明提供了制备含银抗菌制品的方法。所述含银抗菌制品为含银纤维、含银织物或含银聚氨酯材料所述方法包括:In another aspect, the invention provides a method of making a silver-containing antimicrobial article. The silver-containing antibacterial article is a silver-containing fiber, a silver-containing fabric or a silver-containing polyurethane material, and the method comprises the following steps:
(1)将纤维、织物或聚氨酯材料浸渍在溶剂中,所述溶剂选自乙醇、水或它们的组合;(1) immersing the fiber, fabric or polyurethane material in a solvent selected from the group consisting of ethanol, water or a combination thereof;
(2)将含银物质添加至醇胺中,从而获得含银的醇胺螯合物,所述含银物质选自硝酸银、硫酸银、氯化银、氧化银、碳酸银、醋酸银或草酸银;所述醇胺是一种含有氨基和羟基的有机物,其中醇胺与银离子的摩尔比为1:1~10:1,优选为1.5:1~3:1;(2) adding a silver-containing substance to the alcohol amine to obtain a silver-containing alcohol amine chelate selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or a silver oxalate; the alcohol amine is an organic substance containing an amino group and a hydroxyl group, wherein the molar ratio of the alcohol amine to the silver ion is 1:1 to 10:1, preferably 1.5:1 to 3:1;
(3)将所述含银的醇胺螯合物添加至步骤(1)的混合物中,使得纤维、织物或聚氨酯材料在25~80℃下浸渍1-120分钟,然后取出烘干,从而获得所述含银抗菌制品。(3) adding the silver-containing alcohol amine chelate to the mixture of the step (1), so that the fiber, fabric or polyurethane material is immersed at 25 to 80 ° C for 1 to 120 minutes, and then taken out and dried to obtain The silver-containing antibacterial article.
在一个实施方案中,含银抗菌制品为含银纤维、含银织物或含银聚氨酯材料,制备含银抗菌制品的方法包括如下步骤:In one embodiment, the silver-containing antimicrobial article is a silver-containing fiber, a silver-containing fabric, or a silver-containing polyurethane material, and the method of preparing a silver-containing antimicrobial article includes the following steps:
(1)将醇胺溶解在溶剂中,所述溶剂选自乙醇、水或它们的组合, 所述醇胺是一种含有氨基和羟基的有机物;(1) dissolving an alcohol amine in a solvent selected from the group consisting of ethanol, water, or a combination thereof, the alcohol amine being an organic substance containing an amino group and a hydroxyl group;
(2)将纤维、织物或聚氨酯材料浸渍于步骤(1)的醇胺溶液中;(2) immersing the fiber, fabric or polyurethane material in the alcohol amine solution of step (1);
(3)将含银物质分散于溶剂中,从而获得含银离子的溶液或分散体,所述含银物质选自硝酸银、硫酸银、氯化银、氧化银、碳酸银、醋酸银或草酸银,所述溶剂选自乙醇、水或它们的组合;(3) dispersing a silver-containing substance in a solvent to obtain a silver ion-containing solution or dispersion selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or oxalic acid Silver, the solvent being selected from the group consisting of ethanol, water, or a combination thereof;
(4)在25-80℃下将所述含银物质的溶液或分散体添加至步骤(2)的混合物中,并静置1-120分钟,然后取出烘干,从而获得所述含银抗菌制品,其中醇胺与银离子的摩尔比为1:1~10:1,优选为1.5:1~3:1。(4) adding the solution or dispersion of the silver-containing substance to the mixture of the step (2) at 25-80 ° C, and allowing to stand for 1-120 minutes, and then taking out and drying to obtain the silver-containing antibacterial agent. The article wherein the molar ratio of the alkanolamine to the silver ion is from 1:1 to 10:1, preferably from 1.5:1 to 3:1.
在一个实施方案中,含银抗菌制品为含银纤维,制备含银抗菌制品的方法如下:In one embodiment, the silver-containing antimicrobial article is a silver-containing fiber, and the method of preparing the silver-containing antimicrobial article is as follows:
(1)按照常规湿法纺丝方法制备纤维纺丝液,所述纤维选自海藻酸盐纤维、壳聚糖纤维、粘胶纤维、莱赛尔纤维或海丝纤维;(1) preparing a fiber spinning solution according to a conventional wet spinning method, the fiber being selected from the group consisting of alginate fibers, chitosan fibers, viscose fibers, lyocell fibers or sea ray fibers;
(2)将含银物质添加至醇胺中,从而获得含银的醇胺螯合物,所述含银物质选自硝酸银、硫酸银、氯化银、氧化银、碳酸银、醋酸银或草酸银,所述醇胺是一种含有氨基和羟基的有机物,醇胺与银离子的摩尔比为1:1~10:1;优选为1.5:1~3:1;(2) adding a silver-containing substance to the alcohol amine to obtain a silver-containing alcohol amine chelate selected from the group consisting of silver nitrate, silver sulfate, silver chloride, silver oxide, silver carbonate, silver acetate or Silver oxalate, the alcohol amine is an organic substance containing an amino group and a hydroxyl group, the molar ratio of the alcohol amine to the silver ion is 1:1 to 10:1; preferably 1.5:1 to 3:1;
(3)将所述含银的醇胺螯合物添加至所述纺丝液,并搅拌均匀,从而得到含银纺丝液;(3) adding the silver-containing alcohol amine chelate to the spinning solution, and stirring uniformly to obtain a silver-containing spinning solution;
(4)使用所述含银纺丝液纺丝并烘干,从而得到所述含银抗菌制品。(4) Spinning and drying using the silver-containing spinning solution to obtain the silver-containing antibacterial article.
在一个实施方案中,将纺丝得到含银抗菌制品进行羧甲基化、羧乙基化、酰化或磺酰基化改性而得到。在本发明的涉及浸渍过程的方法中,生成的含银的醇胺螯合物可通过静电作用而与制品的特定位点结合,进而得到含银醇胺螯合物的含银抗菌性材料。In one embodiment, the spinning obtained silver-containing antimicrobial article is obtained by carboxymethylation, carboxyethylation, acylation or sulfonylation modification. In the method of the present invention relating to the impregnation process, the resulting silver-containing alcohol amine chelate can be combined with a specific site of the article by electrostatic action to thereby obtain a silver-containing antimicrobial material containing a silver alcohol amine chelate.
在本发明的涉及浸渍过程的方法中,所用的纤维可以是短纤,也可以是长丝,且长丝可更有利于浸渍处理加工。如果使用长丝,则可在浸渍之后切断成长度为5-125毫米的短纤,以便于进一步加工。In the method of the present invention relating to the impregnation process, the fibers used may be staple fibers or filaments, and the filaments may be more advantageous for the impregnation treatment. If filaments are used, they can be cut into staple lengths of 5-125 mm after impregnation for further processing.
在本发明的涉及浸渍过程的方法中,所用的织物包括海藻酸盐织物、壳聚糖织物、酰化壳聚糖织物、羧乙基纤维素织物、磺酰基纤维织物、丙纶织物、绦纶织物和尼纶纤维织物。这些织物可以是机织物、针织物,或非织造物,其克重在12-600克/平方米之间。所述织物经本 发明的方法处理之后,可进一步经过裁切、包装和灭菌后,从而制成含银抗菌敷料,所述含银抗菌敷料的含银量为0.01-10重量%,按含银抗菌敷料的重量计。In the method of the present invention relating to the impregnation process, the fabric used includes alginate fabric, chitosan fabric, acylated chitosan fabric, carboxyethyl cellulose fabric, sulfonyl fiber fabric, polypropylene fabric, and rayon fabric. And nylon fabric. These fabrics may be woven, knitted, or nonwoven having a basis weight between 12 and 600 grams per square meter. After the fabric is processed by the method of the present invention, it can be further cut, packaged and sterilized to prepare a silver-containing antibacterial dressing, wherein the silver-containing antibacterial dressing has a silver content of 0.01-10% by weight, including The weight of the silver antibacterial dressing.
在敷料工业界,一般将厚度在1毫米以下的多孔聚氨酯材料称为薄膜,将厚度为1毫米以上的多孔聚氨酯材料称为海绵。在本发明的涉及浸渍过程的方法中,所用的聚氨酯材料可以是厚度为0.1-1毫米的聚氨酯薄膜或厚度为1-10毫米的聚氨酯海棉。所述聚氨酯材料经本发明的方法处理之后,可进一步经过裁切、包装和灭菌后,从而制成含银抗菌敷料,所述含银抗菌聚氨酯敷料的含银量为0.01-10重量%,按含银抗菌敷料的重量计。在本发明的涉及浸渍过程的方法中,如果所述可吸湿的含银抗菌制品为溶胶性的制品,例如含银海藻酸盐纤维或者织物、含银羧甲基纤维素纤维或织物、含银酰化壳聚糖纤维或织物、含银羧乙基纤维或者织物、含银磺酰基纤维或织物,由于溶胶性纤维在水溶液中会不可逆地形成凝胶,因此所用的溶剂应为乙醇和水的混合物,以避免形成不可逆的凝胶。一般来说,溶剂中乙醇与水的体积比可大于1:1,溶剂的用量可为可吸湿的含银抗菌制品重量的30倍以上。如果所述可吸湿的含银抗菌制品为非溶剂性的制品,例如含银绦纶纤维或者织物、含银丙纶纤维或者织物、含银莱赛尔纤维或者织物、含银粘胶纤维或者织物、含银非改性壳聚糖纤维或织物和含银聚氨酯材料等等,则可以适当调节溶液中水和乙醇之间的比例,适当增加水的比例而减少乙醇的比例,甚至溶剂可全部由水组成。In the dressing industry, a porous polyurethane material having a thickness of 1 mm or less is generally referred to as a film, and a porous polyurethane material having a thickness of 1 mm or more is referred to as a sponge. In the method of the present invention relating to the impregnation process, the polyurethane material used may be a polyurethane film having a thickness of 0.1 to 1 mm or a polyurethane sponge having a thickness of 1 to 10 mm. After the polyurethane material is processed by the method of the invention, it can be further cut, packaged and sterilized to prepare a silver-containing antibacterial dressing, wherein the silver-containing antibacterial polyurethane dressing has a silver content of 0.01-10% by weight. Based on the weight of the silver-containing antimicrobial dressing. In the method of the present invention relating to the impregnation process, if the hygroscopic silver-containing antibacterial article is a sol-formed article, such as silver-containing alginate fibers or fabrics, silver-containing carboxymethylcellulose fibers or fabrics, silver-containing Acylated chitosan fibers or fabrics, silver-containing carboxyethyl fibers or fabrics, silver-containing sulfonyl fibers or fabrics, since the sol fibers irreversibly form a gel in aqueous solution, the solvent used should be ethanol and water. Mixture to avoid the formation of an irreversible gel. Generally, the volume ratio of ethanol to water in the solvent can be greater than 1:1, and the solvent can be used in an amount of more than 30 times the weight of the hygroscopic silver-containing antimicrobial article. If the hygroscopic silver-containing antibacterial article is a non-solvent article, such as silver-containing rayon fibers or fabrics, silver-containing polypropylene fibers or fabrics, silver-containing lyocell fibers or fabrics, silver-containing viscose fibers or fabrics, Silver-containing non-modified chitosan fiber or fabric and silver-containing polyurethane material, etc., can properly adjust the ratio between water and ethanol in the solution, appropriately increase the proportion of water to reduce the proportion of ethanol, even the solvent can be all from water composition.
在本发明的涉及纺丝过程的方法中,可将含银的醇胺螯合物直接加到纤维纺丝液中,再通过公知的纺丝工艺纺成含银纤维。所述方法适用于湿法或溶剂法纺丝纤维,如含银海藻酸盐纤维、含银壳聚糖纤维、含银粘胶纤维、含银莱赛尔纤维或含银海丝纤维。由于含银的醇胺螯合物在一般情况下非常稳定,因此非常适合这些纤维的制备。此外,由于这些纤维的纺丝液一般都很粘稠,有利于防止含银螯合物的析出和再团聚,因此在搅拌均匀后即可直接纺织含银纤维。In the process of the present invention relating to the spinning process, the silver-containing alkamine chelate can be directly added to the fiber spinning solution and spun into a silver-containing fiber by a known spinning process. The method is suitable for wet or solvent-spun fibers such as silver-containing alginate fibers, silver-containing chitosan fibers, silver-containing viscose fibers, silver-containing lyocell fibers or silver-containing sea-hair fibers. Since silver-containing alkanolamine chelates are generally very stable, they are very suitable for the preparation of these fibers. In addition, since the spinning solutions of these fibers are generally very viscous, it is advantageous to prevent precipitation and re-agglomeration of the silver-containing chelate compound, so that the silver-containing fibers can be directly woven after being uniformly stirred.
此外,还可以将通过上述方法制得的含银纤维通过机织、针织或者非织造的方式制备成含银织物。这些含银织物可以经裁切、包装和灭菌,从而进一步制成含银抗菌敷料。Further, the silver-containing fiber obtained by the above method can also be prepared into a silver-containing fabric by woven, knitted or non-woven. These silver-containing fabrics can be cut, packaged and sterilized to further form a silver-containing antimicrobial dressing.
由本发明的上述方法制得的含银纤维、含银织物、含银聚氨酯材料或进一步的含银抗菌敷料的含银量为0.01-10重量%,以含银纤维或含银织物或含银聚氨酯材料或者含银抗菌敷料的重量计,克重12-600克/平方米。The silver-containing fiber, the silver-containing fabric, the silver-containing polyurethane material or the further silver-containing antimicrobial dressing prepared by the above method of the present invention has a silver content of 0.01 to 10% by weight, and comprises a silver fiber or a silver-containing fabric or a silver-containing polyurethane. The weight of the material or silver-containing antibacterial dressing is 12-600 g/m2.
由本发明的方法制得的非溶胶性的纤维或织物可进一步进行化学改性处理,从而增加其吸湿性能或成胶性能。例如,粘胶纤维经过羧甲基化、羧乙基化或者磺酰化分别可以得到羧甲基化纤维素、羧乙基化纤维素和磺酰基纤维素;壳聚糖经过羧甲基化或者酰化分别可以得到羧甲基化壳聚糖或者酰化壳聚糖。The non-solifying fibers or fabrics produced by the process of the present invention can be further chemically modified to increase their moisture absorption properties or gel forming properties. For example, viscose fibers can be carboxymethylated, carboxyethylated or sulfonylated to give carboxymethylated cellulose, carboxyethylated cellulose, and sulfonyl cellulose; chitosan is carboxymethylated or Acylation can respectively give carboxymethylated chitosan or acylated chitosan.
本发明所述的灭菌方式包括钴60辐照、环氧乙烷、电子束和高温等。The sterilization method of the present invention includes cobalt 60 irradiation, ethylene oxide, electron beam, high temperature and the like.
本发明的制品的吸湿性使用BS:EN13726-1-2002方法测试,含银量用原子吸收分光光度计测试。The hygroscopicity of the articles of the present invention was tested using the method of BS: EN13726-1-2002, and the amount of silver contained was tested by an atomic absorption spectrophotometer.
本发明所提及的含银抗菌制品(纤维、织物或聚氨酯材料)和含银抗菌敷料的吸湿性有两种表示方法:g/g和g/100cm 2。这两种表示方法可以通过织物或者敷料的克重联系起来,例如,一种含银壳聚糖敷料的吸湿性是23g/g,此敷料的克重是130gsm(g/m 2),则此敷料的吸湿性也可以表示成23g/gX130gsmX10 -2=29.9g/100cm 2。 The hygroscopicity of the silver-containing antimicrobial articles (fiber, fabric or polyurethane materials) and silver-containing antimicrobial dressings referred to in the present invention are represented by two methods: g/g and g/100 cm 2 . These two representations can be linked by the weight of the fabric or dressing. For example, a silver-containing chitosan dressing has a hygroscopicity of 23 g/g and a dressing weight of 130 gsm (g/m 2 ). The hygroscopicity of the dressing can also be expressed as 23 g/g X 130 gsm X 10 -2 = 29.9 g / 100 cm 2 .
本发明的含银的醇胺螯合物作为抗菌成分的含银抗菌制品具有很广的抗菌谱,对格兰氏阴性菌和格兰氏阳性菌表现出很强的抗菌活性,而且作用迅速和具有光稳定性,可以广泛应用于慢性感染性渗出性伤口,例如糖尿病足、褥疮和一些洞穴型伤口,为伤口的愈合提供一个湿润的环境和抗感染的屏障。The silver-containing alcohol amine chelate of the invention has a broad antibacterial spectrum as an antibacterial component, and exhibits strong antibacterial activity against gram-negative bacteria and gram-positive bacteria, and has a rapid effect and It has light stability and can be widely used in chronic infectious exudative wounds, such as diabetic foot, acne and some cave-type wounds, providing a moist environment and an anti-infective barrier for wound healing.
图1显示为实施例22所制备的含有0.5重量%银离子的敷料在金黄色葡萄球菌培养皿1天后的抑菌圈。Figure 1 shows the zone of inhibition of the dressing containing 0.5% by weight of silver ions prepared in Example 22 after 1 day in a S. aureus culture dish.
图2显示为实施例23所制备的含有0.55重量%银离子的敷料在金黄色葡萄球菌培养皿3天后的抑菌圈。Figure 2 shows the zone of inhibition of the dressing containing 0.55% by weight of silver ions prepared in Example 23 after 3 days in a S. aureus culture dish.
图3显示为实施例24所制备的含有0.79重量%银离子的敷料在金黄色葡萄球菌培养皿1天后的抑菌圈。Figure 3 shows the zone of inhibition of the dressing containing 0.79 wt% silver ion prepared in Example 24 after 1 day in a S. aureus culture dish.
图4显示为实施例26所制备的含有0.3重量%银离子的敷料在金黄色葡萄球菌培养皿3天后的抑菌圈。Figure 4 shows the zone of inhibition of the dressing containing 0.3% by weight of silver ions prepared in Example 26 after 3 days in a S. aureus culture dish.
图5显示为实施例28所制备的含有0.8重量%银离子的敷料在金黄色葡萄球菌培养皿1天后的抑菌圈。Figure 5 shows the zone of inhibition of the dressing containing 0.8% by weight of silver ions prepared in Example 28 after 1 day in a S. aureus culture dish.
图6显示为实施例33所制备的含有0.93%重量%银离子的敷料在金黄色葡萄球菌培养皿3天后的抑菌圈。Figure 6 shows the zone of inhibition of the dressing containing 0.93% by weight of silver ions prepared in Example 33 after 3 days in a S. aureus culture dish.
图7显示为实施例36所制备的含有0.83重量%银离子的敷料在金黄色葡萄球菌培养皿1天后的抑菌圈。Figure 7 shows the zone of inhibition of the dressing containing 0.83 wt% silver ions prepared in Example 36 after 1 day in a S. aureus culture dish.
图8显示为实施例39所制备的含有2.8重量%银离子的敷料在金黄色葡萄球菌培养皿3天后的抑菌圈。Figure 8 shows the zone of inhibition of the dressing containing 2.8% by weight of silver ions prepared in Example 39 after 3 days in a S. aureus culture dish.
实施例1Example 1
乙醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of ethanolamine to silver ion (silver acetate) of 2:1:
(1)把0.32ml的乙醇胺(16.6mol/L)先用30ml无水乙醇稀释得到乙醇胺的乙醇溶液;(1) 0.32 ml of ethanolamine (16.6 mol / L) was first diluted with 30 ml of absolute ethanol to obtain an ethanolamine ethanol solution;
(2)称量0.46g的乙酸银粉末;(2) weighing 0.46 g of silver acetate powder;
(3)把上述乙醇胺溶液用胶头滴管缓慢加到乙酸银中,边加边搅拌,直至乙酸银溶解得到含银的乙醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above ethanolamine solution to the silver acetate with a rubber dropper, stirring while stirring, until the silver acetate is dissolved to obtain a silver-containing ethanolamine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例2Example 2
乙醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of ethanolamine to silver ion (silver acetate) of 2:1:
(1)把1.62ml的乙醇胺(16.6mol/L)先用300ml无水乙醇稀释得到乙醇胺的乙醇溶液;(1) Diluting 1.62 ml of ethanolamine (16.6 mol/L) with 300 ml of absolute ethanol to obtain an ethanolamine ethanol solution;
(2)称量2.3g的乙酸银粉末,并分散到50ml无水乙醇中,形成混悬液;(2) Weigh 2.3 g of silver acetate powder and disperse into 50 ml of absolute ethanol to form a suspension;
(3)把上述乙酸银混悬液缓慢加至乙醇胺的乙醇溶液中,边加边搅拌,直至乙酸银溶解得到含银的乙醇胺螯合物溶液,静置得到无色 透明溶液;(3) slowly adding the above silver acetate suspension to an ethanol solution of ethanolamine, stirring while stirring, until silver acetate is dissolved to obtain a silver-containing ethanolamine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例3Example 3
乙醇胺与银离子(碳酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of ethanolamine to silver ion (silver carbonate) of 2:1:
(1)把15.6ml的乙醇胺(16.6mol/L)先用300ml无水乙醇稀释得到乙醇胺的乙醇溶液;(1) 15.6 ml of ethanolamine (16.6 mol / L) was first diluted with 300 ml of absolute ethanol to obtain an ethanolamine ethanol solution;
(2)称量7.6g的碳酸银粉末;(2) weighing 7.6 g of silver carbonate powder;
(3)把上述乙醇胺溶液用胶头滴管缓慢加到碳酸银中,边加边搅拌,直至碳酸银溶解得到含银的乙醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above ethanolamine solution to the silver carbonate with a rubber dropper, stirring while adding, until the silver carbonate is dissolved to obtain a silver-containing ethanolamine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例4Example 4
乙醇胺与银离子(硫酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of ethanolamine to silver ion (silver sulfate) of 2:1:
(1)把18.3ml的乙醇胺(16.6mol/L)先用300ml无水乙醇稀释得到乙醇胺的乙醇溶液;(1) 18.3 ml of ethanolamine (16.6 mol / L) was first diluted with 300 ml of absolute ethanol to obtain an ethanolamine ethanol solution;
(2)称量8.6g的硫酸银粉末,并分散至50ml纯水中,形成混悬液;(2) Weigh 8.6 g of silver sulfate powder and disperse into 50 ml of pure water to form a suspension;
(3)把上述硫酸银混悬液缓慢加至乙醇胺的乙醇溶液中,边加边搅拌,直至硫酸银溶解得到含银的乙醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above silver sulfate suspension to an ethanol solution of ethanolamine, stirring while adding, until silver sulfate is dissolved to obtain a silver-containing ethanolamine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例5Example 5
乙醇胺与银离子(硝酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of ethanolamine to silver ion (silver nitrate) of 2:1:
(1)把1.62ml的乙醇胺(16.6mol/L)先用300ml无水乙醇稀释得到乙醇胺的乙醇溶液;(1) Diluting 1.62 ml of ethanolamine (16.6 mol/L) with 300 ml of absolute ethanol to obtain an ethanolamine ethanol solution;
(2)称量2.34g的硝酸银粉末,并加入氢氧化钠溶液使其生成黑色沉淀;(2) Weigh 2.34g of silver nitrate powder and add sodium hydroxide solution to form a black precipitate;
(3)把上述乙醇胺溶液用胶头滴管缓慢加到黑色沉淀中,边加边 搅拌,直至黑色沉淀溶解得到含银的乙醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above ethanolamine solution to the black precipitate with a rubber dropper, stirring while adding, until the black precipitate dissolves to obtain a silver-containing ethanolamine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例6Example 6
乙醇胺与银离子(乙酸银)的摩尔比为5:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of ethanolamine to silver ion (silver acetate) of 5:1:
(1)把8.1ml的乙醇胺(16.6mol/L)先用300ml无水乙醇稀释得到乙醇胺的乙醇溶液;(1) 8.1 ml of ethanolamine (16.6 mol / L) was first diluted with 300 ml of absolute ethanol to obtain an ethanolamine ethanol solution;
(2)称量2.3g的乙酸银粉末,并添加至50ml纯水中,形成混悬液;(2) Weigh 2.3 g of silver acetate powder and add to 50 ml of pure water to form a suspension;
(3)把上述乙酸银混悬液缓慢加至乙醇胺的乙醇溶液,边加边搅拌,直至乙酸银溶解得到含银的乙醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above silver acetate suspension to an ethanol solution of ethanolamine, stirring while adding, until silver acetate is dissolved to obtain a silver-containing ethanolamine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例7Example 7
乙醇胺与银离子(碳酸银)的摩尔比为5:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of ethanolamine to silver ion (silver carbonate) of 5:1:
(1)把78ml的乙醇胺(16.6mol/L)先用300ml无水乙醇稀释得到乙醇胺的乙醇溶液;(1) 78 ml of ethanolamine (16.6 mol / L) was first diluted with 300 ml of absolute ethanol to obtain an ethanolamine ethanol solution;
(2)称量7.6g的碳酸银粉末;(2) weighing 7.6 g of silver carbonate powder;
(3)把上述乙醇胺溶液用胶头滴管缓慢加到碳酸银中,边加边搅拌,直至碳酸银溶解得到含银的乙醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above ethanolamine solution to the silver carbonate with a rubber dropper, stirring while adding, until the silver carbonate is dissolved to obtain a silver-containing ethanolamine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例8Example 8
乙醇胺与银离子(硫酸银)的摩尔比为5:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of ethanolamine to silver ion (silver sulfate) of 5:1:
(1)把91.5ml的乙醇胺先用300ml无水乙醇稀释得到乙醇胺的乙醇溶液;(1) 91.5 ml of ethanolamine is first diluted with 300 ml of absolute ethanol to obtain an ethanolamine ethanol solution;
(2)称量8.6g的硫酸银粉末;(2) weighing 8.6 g of silver sulfate powder;
(3)把上述乙醇胺溶液用胶头滴管缓慢加到硫酸银中,边加边搅 拌,直至硫酸银溶解得到含银的乙醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above ethanolamine solution to the silver sulfate with a rubber dropper, and stirring until the silver sulfate is dissolved to obtain a silver-containing ethanolamine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例9Example 9
丙醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of propanolamine to silver ion (silver acetate) of 2:1:
(1)把2.021g的丙醇胺先用300ml无水乙醇稀释得到丙醇胺的乙醇溶液;(1) 2.021 g of propanolamine is first diluted with 300 ml of absolute ethanol to obtain a solution of propanolamine in ethanol;
(2)称量2.3g的乙酸银粉末,并分散至60ml无水乙醇中,形成混悬液;(2) weighing 2.3 g of silver acetate powder and dispersing into 60 ml of absolute ethanol to form a suspension;
(3)把上述乙酸银混悬液缓慢加至丙醇胺的乙醇溶液中,边加边搅拌,直至乙酸银溶解得到含银的丙醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above silver acetate suspension to the ethanol solution of propanolamine, stirring while stirring, until the silver acetate is dissolved to obtain a silver-containing propanolamine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例10Example 10
1-甲基-乙醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution with a molar ratio of 1-methyl-ethanolamine to silver ion (silver acetate) of 2:1:
(1)把2.021g的1-甲基-乙醇胺先用300ml无水乙醇稀释得到1-甲基-乙醇胺的乙醇溶液;(1) 2.021 g of 1-methyl-ethanolamine is first diluted with 300 ml of absolute ethanol to obtain a solution of 1-methyl-ethanolamine in ethanol;
(2)称量2.3g的乙酸银粉末;(2) weighing 2.3 g of silver acetate powder;
(3)把上述1-甲基-乙醇胺溶液用胶头滴管缓慢加到乙酸银中,边加边搅拌,直至乙酸银溶解得到含银的醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above 1-methyl-ethanolamine solution to the silver acetate with a plastic pipette, stirring while stirring, until the silver acetate is dissolved to obtain a silver-containing alcohol amine chelate solution, and standing still to obtain a colorless transparent Solution
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例11Example 11
2-甲基-乙醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution with a molar ratio of 2-methyl-ethanolamine to silver ion (silver acetate) of 2:1:
(1)把2.021g的2-甲基-乙醇胺先用300ml无水乙醇稀释得到2-甲基-乙醇胺的乙醇溶液;(1) 2.021 g of 2-methyl-ethanolamine is first diluted with 300 ml of absolute ethanol to obtain a solution of 2-methyl-ethanolamine in ethanol;
(2)称量2.3g的乙酸银粉末,并分散至50ml纯水中,形成乙酸银混悬液;(2) weighing 2.3 g of silver acetate powder and dispersing into 50 ml of pure water to form a silver acetate suspension;
(3)把上述乙酸银混悬液缓慢加至乙醇胺的乙醇溶液中,边加边搅拌,直至乙酸银溶解得到含银的醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above silver acetate suspension to an ethanol solution of ethanolamine, stirring while stirring, until silver acetate is dissolved to obtain a silver-containing alcohol amine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例12Example 12
正丁醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution with a molar ratio of n-butanolamine to silver ion (silver acetate) of 2:1:
(1)把2.48g的正丁醇胺先用300ml无水乙醇稀释得到正丁醇胺的乙醇溶液;(1) 2.48 g of n-butanolamine is first diluted with 300 ml of absolute ethanol to obtain an ethanol solution of n-butanolamine;
(2)称量2.3g的乙酸银粉末;(2) weighing 2.3 g of silver acetate powder;
(3)把上述正丁醇胺溶液用胶头滴管缓慢加到乙酸银中,边加边搅拌,直至乙酸银溶解得到含银的正丁醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above n-butanolamine solution to the silver acetate with a rubber dropper, stirring while stirring, until the silver acetate is dissolved to obtain a silver-containing n-butanolamine chelate solution, and standing still to obtain a colorless transparent Solution
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例13Example 13
1-甲基-丙醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution with a molar ratio of 1-methyl-propanolamine to silver ion (silver acetate) of 2:1:
(1)把2.48g的1-甲基-丙醇胺先用300ml无水乙醇稀释得到1-甲基-丙醇胺的乙醇溶液;(1) 2.48 g of 1-methyl-propanolamine is first diluted with 300 ml of absolute ethanol to obtain a solution of 1-methyl-propanolamine in ethanol;
(2)称量2.3g的乙酸银粉末;(2) weighing 2.3 g of silver acetate powder;
(3)把上述1-甲基-丙醇胺溶液用胶头滴管缓慢加到乙酸银中,边加边搅拌,直至乙酸银溶解得到含银的醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above 1-methyl-propanolamine solution to the silver acetate with a rubber dropper, stirring while stirring, until the silver acetate is dissolved to obtain a silver-containing alcohol amine chelate solution, and standing still to obtain no Color transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例14Example 14
2-甲基-丙醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution with a molar ratio of 2-methyl-propanolamine to silver ion (silver acetate) of 2:1:
(1)把2.48g的2-甲基-丙醇胺先用300ml无水乙醇稀释得到2-甲基-丙醇胺的乙醇溶液;(1) 2.48 g of 2-methyl-propanolamine is first diluted with 300 ml of absolute ethanol to obtain a solution of 2-methyl-propanolamine in ethanol;
(2)称量2.3g的乙酸银粉末;(2) weighing 2.3 g of silver acetate powder;
(3)把上述2-甲基-丙醇胺溶液用胶头滴管缓慢加到乙酸银中, 边加边搅拌,直至乙酸银溶解得到含银的醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above 2-methyl-propanolamine solution to the silver acetate with a rubber dropper, stirring while stirring, until the silver acetate is dissolved to obtain a silver-containing alcohol amine chelate solution, and standing still to obtain no Color transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例15Example 15
1,2-二甲基乙醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of 1,2-dimethylethanolamine to silver ion (silver acetate) of 2:1:
(1)把2.48g的1,2-二甲基乙醇胺先用300ml无水乙醇稀释得到1,2-二甲基乙醇胺的乙醇溶液;(1) 2.48 g of 1,2-dimethylethanolamine is first diluted with 300 ml of absolute ethanol to obtain a solution of 1,2-dimethylethanolamine in ethanol;
(2)称量2.3g的乙酸银粉末;(2) weighing 2.3 g of silver acetate powder;
(3)把上述1,2-二甲基乙醇胺溶液用胶头滴管缓慢加到乙酸银中,边加边搅拌,直至乙酸银溶解得到含银的醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above 1,2-dimethylethanolamine solution to the silver acetate with a rubber dropper, stirring while stirring, until the silver acetate is dissolved to obtain a silver-containing alcohol amine chelate solution, and standing still to obtain no Color transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例16Example 16
甲醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of methanolamine to silver ion (silver acetate) of 2:1:
(1)把1.31g的甲醇胺先用300ml无水乙醇稀释得到甲醇胺的乙醇溶液;(1) 1.31 g of methanolamine is first diluted with 300 ml of absolute ethanol to obtain a methanol solution of methanolamine;
(2)称量2.3g的乙酸银粉末;(2) weighing 2.3 g of silver acetate powder;
(3)把上述甲醇胺溶液用胶头滴管缓慢加到乙酸银中,边加边搅拌,直至乙酸银溶解得到含银的醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above methanolamine solution to the silver acetate with a plastic pipette, stirring while stirring, until the silver acetate is dissolved to obtain a silver-containing alcohol amine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例17Example 17
乙醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of ethanolamine to silver ion (silver acetate) of 2:1:
(1)把1.62ml的乙醇胺(16.6mol/L)先用300ml蒸馏水稀释得到乙醇胺的水溶液;(1) Diluting 1.62 ml of ethanolamine (16.6 mol/L) with 300 ml of distilled water to obtain an aqueous solution of ethanolamine;
(2)称量2.3g的乙酸银粉末;(2) weighing 2.3 g of silver acetate powder;
(3)把上述乙醇胺溶液用胶头滴管缓慢加到乙酸银中,边加边搅拌,直至乙酸银溶解得到含银的醇胺螯合物溶液,静置得到无色透明 溶液;(3) slowly adding the above ethanolamine solution to the silver acetate with a rubber dropper, stirring while stirring, until the silver acetate is dissolved to obtain a silver-containing alcohol amine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例18Example 18
丙醇胺与银离子(乙酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of propanolamine to silver ion (silver acetate) of 2:1:
(1)把2.021g的丙醇胺先用300ml蒸馏水稀释得到丙醇胺的水溶液;(1) 2.021 g of propanolamine is first diluted with 300 ml of distilled water to obtain an aqueous solution of propanolamine;
(2)称量2.3g的乙酸银粉末;(2) weighing 2.3 g of silver acetate powder;
(3)把上述丙醇胺溶液用胶头滴管缓慢加到乙酸银中,边加边搅拌,直至乙酸银溶解得到含银的丙醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above-mentioned propanolamine solution to the silver acetate with a plastic pipette, stirring while stirring, until the silver acetate is dissolved to obtain a silver-containing propanolamine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例19Example 19
丙醇胺与银离子(硫酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of propanolamine to silver ion (silver sulfate) of 2:1:
(1)把19.8g的丙醇胺先用300ml无水乙醇稀释得到丙醇胺的乙醇溶液;(1) 19.8 g of propanolamine is first diluted with 300 ml of absolute ethanol to obtain a solution of propanolamine in ethanol;
(2)称量8.6g的硫酸银粉末;(2) weighing 8.6 g of silver sulfate powder;
(3)把上述丙醇胺溶液用胶头滴管缓慢加到硫酸银中,边加边搅拌,直至硫酸银溶解得到含银的丙醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above-mentioned propanolamine solution to the silver sulfate with a plastic dropper, stirring while stirring, until the silver sulfate is dissolved to obtain a silver-containing propanolamine chelate solution, and standing to obtain a colorless transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例20Example 20
1,2-二甲基乙醇胺与银离子(硫酸银)的摩尔比为2:1的含银的醇胺螯合物溶液的配制:Preparation of a silver-containing alcohol amine chelate solution having a molar ratio of 1,2-dimethylethanolamine to silver ion (silver sulfate) of 2:1:
(1)把24.43g的1,2-二甲基乙醇胺先用300ml无水乙醇稀释得到1,2-二甲基乙醇胺的乙醇溶液;(1) 24.43 g of 1,2-dimethylethanolamine is first diluted with 300 ml of absolute ethanol to obtain a solution of 1,2-dimethylethanolamine in ethanol;
(2)称量8.6g的硫酸银粉末;(2) weighing 8.6 g of silver sulfate powder;
(3)把上述1,2-二甲基乙醇胺溶液用胶头滴管缓慢加到硫酸银中,边加边搅拌,直至硫酸银溶解得到含银的醇胺螯合物溶液,静置得到无色透明溶液;(3) slowly adding the above 1,2-dimethylethanolamine solution to the silver sulfate with a rubber dropper, stirring while stirring, until the silver sulfate is dissolved to obtain a silver-containing alcohol amine chelate solution, and standing still to obtain no Color transparent solution;
以上的配制过程在常温下进行。The above preparation process is carried out at normal temperature.
实施例21Example 21
100g羧甲基改性纤维素纤维在室温下浸泡在2500ml无水酒精中,使其充分浸湿,然后将实施例2所制得的含银的醇胺螯合物溶液添加至上述混合物中,使羧甲基改性纤维素纤维在室温下在溶液中充分浸泡静置30分钟,取出挤干并烘干后,经过常规非织造布工序,并切断、包装和灭菌后,得到含银改性纤维素纤维。所述含银羧甲基改性纤维素敷料的克重为120克/平方米(gsm),吸湿性为22g/g,含银量为0.2%,按含银敷料重量计。含银改性纤维素敷料的pH值为6.1-6.2。100 g of carboxymethyl modified cellulose fiber was immersed in 2500 ml of absolute alcohol at room temperature to sufficiently wet it, and then the silver-containing alcohol amine chelate solution prepared in Example 2 was added to the above mixture. The carboxymethyl modified cellulose fiber is fully immersed in the solution for 30 minutes at room temperature, taken out, squeezed and dried, and then subjected to a conventional nonwoven process, and cut, packaged and sterilized to obtain a silver-containing modification. Cellulose fiber. The silver-containing carboxymethyl modified cellulose dressing has a basis weight of 120 g/m 2 (gsm), a hygroscopicity of 22 g/g, and a silver content of 0.2%, based on the weight of the silver-containing dressing. The pH of the silver-containing modified cellulose dressing is from 6.1 to 6.2.
实施例22Example 22
100g酰化壳聚糖纤维在室温下浸泡在2500ml无水酒精中,使其充分浸湿,然后将实施例2所制得的含银的醇胺螯合物溶液添加至上述混合物中,使酰化壳聚糖纤维在40℃下在溶液中充分浸泡静置,取出挤干并烘干后,经过常规非织造布工序,并切断、包装和灭菌后,得到含银酰化壳聚糖敷料。所述含银酰化壳聚糖敷料的克重为120gsm,吸湿性为20g/100cm 2,按敷料重量计,含银量为0.5%。敷料的pH值为6.8-7.1。本实施例的敷料在金黄色葡萄球菌培养皿1天后的抑菌圈如图1所示,这表明含银的醇胺螯合物的伤口敷料对金黄色葡萄球菌具有一定的抑菌作用。 100 g of the acylated chitosan fiber was immersed in 2500 ml of absolute alcohol at room temperature to sufficiently wet it, and then the silver-containing alcohol amine chelate solution prepared in Example 2 was added to the above mixture to make an acyl group. The chitosan fiber is fully soaked in a solution at 40 ° C, taken out, squeezed and dried, and then subjected to a conventional nonwoven process, and cut, packaged and sterilized to obtain a silver-containing chitosan dressing. . The silver-containing chitosan dressing has a basis weight of 120 gsm and a hygroscopicity of 20 g/100 cm 2 and a silver content of 0.5% by weight of the dressing. The pH of the dressing is 6.8-7.1. The inhibition zone of the dressing of this example after 1 day in the S. aureus culture dish is shown in Figure 1, which indicates that the wound dressing of the silver-containing alkamine chelate has a certain bacteriostatic effect on S. aureus.
实施例23Example 23
100g粘胶纤维在室温下浸泡在2500ml纯水中,使其充分浸湿,然后将实施例3所制得的含银的醇胺螯合物溶液添加至上述混合物中,然后使粘胶纤维在45℃下在溶液中充分浸泡静置120分钟,取出挤干并烘干后,经过常规非织造工序,并切断、包装和灭菌后,得到含银粘胶纤维敷料。所述含银粘胶纤维敷料的克重为110gsm,吸湿性为12g/100cm 2,按敷料重量计,含银量为0.55重量%。敷料的pH值为4.3-6.8。本实施例的敷料在金黄色葡萄球菌培养皿3天后的抑菌圈如图2所示,这表明含银的醇胺螯合物的伤口敷料对金黄色葡萄球菌具有一定的抑菌作用。 100 g of viscose fiber was immersed in 2500 ml of pure water at room temperature to sufficiently wet it, and then the silver-containing alcohol amine chelate solution prepared in Example 3 was added to the above mixture, and then the viscose fiber was allowed to be After fully immersing in the solution at 45 ° C for 120 minutes, taken out and squeezed and dried, after a conventional non-woven process, and cut, packaged and sterilized, a silver-containing viscose fiber dressing was obtained. The silver-containing viscose fiber dressing had a basis weight of 110 gsm and a hygroscopicity of 12 g/100 cm 2 and a silver content of 0.55% by weight based on the weight of the dressing. The dressing has a pH of 4.3-6.8. The inhibition zone of the dressing of this example after 3 days in the S. aureus culture dish is shown in Figure 2, which indicates that the wound dressing of the silver-containing alcohol amine chelate has a certain bacteriostatic effect on Staphylococcus aureus.
实施例24Example 24
100g羧甲基壳聚糖非织造物(克重100gsm)在室温下浸泡在 2500ml无水酒精中,使其充分润湿,然后将实施例6所制得的含银的醇胺螯合物溶液添加至上述混合物中,使酰化壳聚糖织物在室温下在溶液中充分浸泡静置30分钟,取出挤干并烘干后,经切断、包装和灭菌后,得到含银酰化壳聚糖敷料,克重为100gsm。所述含银酰化壳聚糖敷料的吸湿性为20g/100cm 2,按敷料重量计,含银量为0.79重量%。敷料的pH值为6.8-7.0。本实施例的敷料在金黄色葡萄球菌培养皿1天后的抑菌圈如图3所示,这表明含银的醇胺螯合物的伤口敷料对金黄色葡萄球菌具有一定的抑菌作用。 100 g of carboxymethyl chitosan nonwoven (gram weight 100 gsm) was immersed in 2500 ml of absolute alcohol at room temperature to sufficiently wet it, and then the silver-containing alcohol amine chelate solution prepared in Example 6 was used. Adding to the above mixture, allowing the acylated chitosan fabric to be fully soaked in the solution at room temperature for 30 minutes, taking out and squeezing and drying, and then cutting, packaging and sterilizing to obtain a silver-containing acylated shell. Sugar dressing, weight is 100gsm. The silver-containing acylated chitosan dressing had a hygroscopicity of 20 g/100 cm 2 and a silver content of 0.79 wt% based on the weight of the dressing. The pH of the dressing is 6.8-7.0. The inhibition zone of the dressing of this example after 1 day in the S. aureus culture dish is shown in Figure 3, which indicates that the wound dressing of the silver-containing alkamine chelate has a certain bacteriostatic effect on S. aureus.
实施例25Example 25
100g粘胶纤维织物(克重为80gsm)在室温下浸泡在2500ml纯水中,使其充分润湿,然后将实施例10所制得的醇胺螯合物溶液添加至上述混合物中,使粘胶纤维织物在60℃下在溶液中充分浸泡静置120分钟,取出挤干并烘干后,经切断、包装和灭菌后,得到含银粘胶纤维敷料,克重为80gsm。所述含银粘胶纤维敷料的吸湿性为10g/100cm 2,按敷料重量计,含银量为1.5重量%。敷料的pH值为5.0-7.0。 100 g of viscose fabric (gram weight of 80 gsm) was immersed in 2500 ml of pure water at room temperature to sufficiently wet it, and then the alcohol amine chelate solution prepared in Example 10 was added to the above mixture to make it sticky. The rubber fiber fabric was fully immersed in the solution at 60 ° C for 120 minutes, taken out, squeezed and dried, and then cut, packaged and sterilized to obtain a silver-containing viscose fiber dressing having a basis weight of 80 gsm. The silver-containing viscose fiber dressing had a hygroscopicity of 10 g/100 cm 2 and a silver content of 1.5% by weight based on the weight of the dressing. The pH of the dressing is 5.0-7.0.
实施例26Example 26
100g聚氨酯薄膜(厚度0.8毫米)在室温下浸泡在2500ml无水酒精中,使其充分浸湿,然后将实施例12中所制得的含银的醇胺螯合物溶液添加至上述混合物中,使聚氨酯薄膜在60℃下在溶液中充分浸泡静置90分钟,取出挤干并烘干后,再经切断、包装和灭菌后,得到含银聚氨酯薄膜敷料。所述含银聚氨酯薄膜敷料的吸湿性为6g/100cm 2,按敷料重量计,含银量为0.3重量%。本实施例的敷料在金黄色葡萄球菌培养皿3天后的抑菌圈如图4所示,这表明含银的醇胺螯合物的伤口敷料对金黄色葡萄球菌具有一定的抑菌作用。 100 g of a polyurethane film (thickness 0.8 mm) was immersed in 2500 ml of absolute alcohol at room temperature to sufficiently wet it, and then the silver-containing alcohol amine chelate solution prepared in Example 12 was added to the above mixture. The polyurethane film was sufficiently immersed in the solution at 60 ° C for 90 minutes, taken out, squeezed and dried, and then cut, packaged and sterilized to obtain a silver-containing polyurethane film dressing. The silver-containing polyurethane film dressing had a hygroscopicity of 6 g/100 cm 2 and a silver content of 0.3% by weight based on the weight of the dressing. The inhibition zone of the dressing of this example after 3 days in the S. aureus culture dish is shown in Figure 4, which indicates that the wound dressing of the silver-containing alkamine chelate has a certain bacteriostatic effect on Staphylococcus aureus.
实施例27Example 27
100g羧甲基改性纤维素纤维在室温下浸泡在2500ml无水酒精中,使其充分润湿,然后将实施例15所制得的含银的醇胺螯合物溶液添加至上述混合物中,使羧甲基改性纤维素纤维在室温下在溶液中充分浸泡静置35分钟,取出挤干并烘干后,经过常规非织造布工序,并切断、包装和灭菌后,得到含银改性纤维素敷料。所述含银羧甲基改性纤维素敷料的克重为126g/100cm 2,吸湿性为24g/g,含银量为0.4%,按含 银敷料重量计。含银改性纤维素敷料的pH值为6.1-6.2。 100 g of carboxymethyl modified cellulose fiber was immersed in 2500 ml of absolute alcohol at room temperature to sufficiently wet it, and then the silver-containing alcohol amine chelate solution prepared in Example 15 was added to the above mixture. The carboxymethyl modified cellulose fiber is fully soaked in the solution at room temperature for 35 minutes, taken out, squeezed and dried, and then subjected to a conventional nonwoven process, and cut, packaged and sterilized to obtain a silver-containing modification. Cellulose dressing. The silver-containing carboxymethyl modified cellulose dressing had a basis weight of 126 g/100 cm 2 , a hygroscopicity of 24 g/g, and a silver content of 0.4%, based on the weight of the silver-containing dressing. The pH of the silver-containing modified cellulose dressing is from 6.1 to 6.2.
实施例28Example 28
100g聚氨酯泡沫(厚度6毫米)在室温下浸泡在2500ml纯水中,使其充分浸湿,然后按实施例16所制得的含银的醇胺螯合物溶液添加至上述混合物中,使聚氨酯泡沫在室温下在溶液中充分浸泡静置100分钟,取出挤干并烘干后,再经切断、包装和灭菌后,得到含银聚氨酯泡沫敷料。所述含银聚氨酯泡沫敷料的吸湿性为25g/100cm 2,按敷料重量计,含银量为0.8重量%。本实施例的敷料在金黄色葡萄球菌培养皿1天后的抑菌圈如图5所示,这表明含银的醇胺螯合物的伤口敷料对金黄色葡萄球菌具有一定的抑菌作用。 100 g of polyurethane foam (thickness: 6 mm) was immersed in 2,500 ml of pure water at room temperature to sufficiently wet it, and then a silver-containing alcohol amine chelate solution prepared in accordance with Example 16 was added to the above mixture to obtain a polyurethane. The foam is fully soaked in the solution at room temperature for 100 minutes, taken out, squeezed and dried, and then cut, packaged and sterilized to obtain a silver-containing polyurethane foam dressing. The silver-containing polyurethane foam dressing had a hygroscopicity of 25 g/100 cm 2 and a silver content of 0.8% by weight based on the weight of the dressing. The inhibition zone of the dressing of this example after 1 day in the S. aureus culture dish is shown in Figure 5, which indicates that the wound dressing of the silver-containing alcohol amine chelate has a certain bacteriostatic effect on Staphylococcus aureus.
实施例29Example 29
(1)将16.2ml乙醇胺溶解于2500ml的无水酒精中,得到乙醇胺溶液;(1) Dissolving 16.2 ml of ethanolamine in 2500 ml of anhydrous alcohol to obtain an ethanolamine solution;
(2)将100g羧甲基改性纤维素纤维浸泡在上述乙醇胺溶液中,静置10分钟;(2) 100 g of carboxymethyl modified cellulose fiber was immersed in the above ethanolamine solution, and allowed to stand for 10 minutes;
(3)将4.6g乙酸银加到10ml纯水中然后将所得分散体溶液加至上述浸泡有纤维的溶液中。(3) 4.6 g of silver acetate was added to 10 ml of pure water and the resulting dispersion solution was added to the above-mentioned fiber-impregnated solution.
以上操作均在室温下进行。将纤维取出,挤干并烘干后,得到含银羧甲基改性纤维素纤维,其吸湿性为18g/g,含银量为0.8重量%。The above operations were all carried out at room temperature. The fiber was taken out, squeezed and dried to obtain a silver-containing carboxymethyl modified cellulose fiber having a hygroscopicity of 18 g/g and a silver content of 0.8% by weight.
实施例30Example 30
(1)将20ml乙醇胺溶解于2500ml的无水酒精中,得到乙醇胺溶液;(1) dissolving 20 ml of ethanolamine in 2500 ml of anhydrous alcohol to obtain an ethanolamine solution;
(2)将100g酰化壳聚糖纤维浸泡在上述乙醇胺溶液中,静置10分钟;(2) 100 g of acylated chitosan fiber was immersed in the above ethanolamine solution, and allowed to stand for 10 minutes;
(3)将5.3g乙酸银加到10ml纯水中然后将所得分散体溶液加至上述浸泡有纤维的溶液中。以上操作均在50℃下进行。(3) 5.3 g of silver acetate was added to 10 ml of pure water and the resulting dispersion solution was added to the above-mentioned fiber-impregnated solution. The above operations were all carried out at 50 °C.
将纤维取出,挤干并烘干后,经过常规非织造布工序,并切断、包装和灭菌后,得到含银酰化壳聚糖敷料。所述含银酰化壳聚糖敷料的克重为135gsm,吸湿性为22g/100cm 2,按敷料重量计,含银量为0.6重量%。敷料pH值为6.5。 The fiber is taken out, squeezed and dried, and then subjected to a conventional nonwoven process, and cut, packaged, and sterilized to obtain a silver-containing chitosan dressing. The silver-containing acylated chitosan dressing had a basis weight of 135 gsm and a hygroscopicity of 22 g/100 cm 2 and a silver content of 0.6% by weight based on the weight of the dressing. The dressing has a pH of 6.5.
实施例31Example 31
(1)将20.21g的1-甲基-乙醇胺先用3000ml无水乙醇稀释得到1-甲基-乙醇胺的乙醇溶液;(1) 20.21 g of 1-methyl-ethanolamine is first diluted with 3000 ml of absolute ethanol to obtain a solution of 1-methyl-ethanolamine in ethanol;
(2)将100g粘胶纤维浸泡在上述醇胺溶液中,静置70分钟;(2) immersing 100 g of viscose fiber in the above alcohol amine solution and allowing to stand for 70 minutes;
(3)将23g乙酸银溶解于50ml纯水中,然后将所得溶液加入至上述浸泡有纤维的醇胺溶液中。以上操作均在65℃下进行。(3) 23 g of silver acetate was dissolved in 50 ml of pure water, and then the resulting solution was added to the above-mentioned fiber-impregnated alcohol amine solution. The above operations were all carried out at 65 °C.
(4)将纤维取出,挤干并烘干后,经过常规非织造布工序,并切断、包装和灭菌后,得到含银粘胶纤维敷料。所述含银粘胶纤维敷料的克重为100gsm,吸湿性为16g/100cm 2,按敷料重量计,含银量为0.7重量%。敷料的pH值为5.5。 (4) The fiber is taken out, squeezed and dried, and then subjected to a conventional nonwoven fabric process, and cut, packaged and sterilized to obtain a silver-containing viscose fiber dressing. The silver-containing viscose fiber dressing had a basis weight of 100 gsm and a hygroscopicity of 16 g/100 cm 2 and a silver content of 0.7% by weight based on the weight of the dressing. The dressing has a pH of 5.5.
实施例32Example 32
(1)将110ml乙醇胺溶解于2500ml的无水酒精中,得到醇胺的乙醇溶液;(1) Dissolving 110 ml of ethanolamine in 2500 ml of anhydrous alcohol to obtain an ethanol solution of an alkanolamine;
(2)将100g羧甲基改性纤维素纤维浸泡在上述醇胺溶液中,静置10分钟;(2) 100 g of carboxymethyl modified cellulose fiber was immersed in the above alcohol amine solution, and allowed to stand for 10 minutes;
(3)将20g硫酸银中加到10ml纯水中然后加入至上述浸泡有纤维的溶液中。(3) 20 g of silver sulfate was added to 10 ml of pure water and then added to the above-mentioned solution in which the fibers were soaked.
以上操作均在45℃下进行。将纤维取出,挤干并烘干后,得到含银羧甲基改性纤维素纤维,其吸湿性为17g/g,含银量为0.9重量%。The above operations were all carried out at 45 °C. The fiber was taken out, squeezed and dried to obtain a silver-containing carboxymethyl modified cellulose fiber having a hygroscopicity of 17 g/g and a silver content of 0.9% by weight.
实施例33Example 33
(1)将30ml乙醇胺溶解于2500ml的纯水中,得到乙醇胺溶液;(1) Dissolving 30 ml of ethanolamine in 2500 ml of pure water to obtain an ethanolamine solution;
(2)将100g粘胶纤维浸泡在上述乙醇胺溶液中,静置70分钟;(2) immersing 100 g of viscose fiber in the above ethanolamine solution and allowing to stand for 70 minutes;
(3)将3.323g氧化银溶解于10ml纯水中,然后将所得溶液加入至上述浸泡有纤维的溶液中。经上操作均在70℃下进行。(3) 3.323 g of silver oxide was dissolved in 10 ml of pure water, and then the resulting solution was added to the above-mentioned fiber-impregnated solution. The above operations were all carried out at 70 °C.
将纤维取出,挤干并烘干后,经过常规非织造布工序,并切断、包装和灭菌后,得到含银粘胶纤维敷料。所述含银粘胶纤维敷料的克重为110gsm,吸湿性为18g/gsm,按敷料重量计,含银量为0.93重量%。敷料的pH值为5。本实施例的敷料在金黄色葡萄球菌培养皿3天后的抑菌圈如图6所示,这表明含银的醇胺螯合物的伤口敷料对金黄色葡萄球菌具有一定的抑菌作用。The fiber is taken out, squeezed and dried, and then subjected to a conventional nonwoven process, and cut, packaged, and sterilized to obtain a silver-containing viscose fiber dressing. The silver-containing viscose fiber dressing had a basis weight of 110 gsm and a hygroscopicity of 18 g/gsm and a silver content of 0.93 wt% based on the weight of the dressing. The pH of the dressing is 5. The inhibition zone of the dressing of this example after 3 days in the S. aureus culture dish is shown in Figure 6, which indicates that the wound dressing of the silver-containing alkamine chelate has a certain bacteriostatic effect on Staphylococcus aureus.
实施例34Example 34
(1)将80ml的乙醇胺加入到2500ml的无水乙醇中,得到乙醇胺 溶液;(1) 80 ml of ethanolamine is added to 2500 ml of absolute ethanol to obtain an ethanolamine solution;
(2)将100g羧甲基改性纤维素非织造物(克重130gsm)浸泡在上述乙醇胺溶液中,静置10分钟;(2) 100 g of carboxymethyl modified cellulose nonwoven (gram weight 130 gsm) was soaked in the above ethanolamine solution, and allowed to stand for 10 minutes;
(3)将9.12g碳酸银溶解于10ml纯水中,然后将所得溶液加入上述浸泡在织物的溶液中。(3) 9.12 g of silver carbonate was dissolved in 10 ml of pure water, and then the resulting solution was added to the above solution soaked in the fabric.
以上操作均在室温下进行。把上述织物取出,挤干并烘干后,经切断、包装和灭菌后,得到含银羧甲基改性纤维素敷料,克重为130gsm。所述含银羧甲基改性纤维素敷料的吸湿性为21g/100cm 2,按敷料重量计,含银量为0.7重量%。敷料的pH值为6.3。 The above operations were all carried out at room temperature. The above fabric was taken out, squeezed and dried, and then cut, packaged and sterilized to obtain a silver-containing carboxymethyl modified cellulose dressing having a basis weight of 130 gsm. The silver-containing carboxymethyl modified cellulose dressing had a hygroscopicity of 21 g/100 cm 2 and a silver content of 0.7% by weight based on the weight of the dressing. The dressing has a pH of 6.3.
实施例35Example 35
(1)将20.23ml乙醇胺溶解到2500ml的无水酒精中,得到乙醇胺溶液;(1) dissolving 20.23 ml of ethanolamine into 2500 ml of anhydrous alcohol to obtain an ethanolamine solution;
(2)将100g酰化壳聚糖非织造物(克重135gsm)浸泡在上述乙醇胺溶液中,静置10分钟;(2) 100 g of acylated chitosan nonwoven (gram weight 135 gsm) was immersed in the above ethanolamine solution, and allowed to stand for 10 minutes;
(3)将5.6g乙酸银加入到10ml纯水中,然后将所得溶液加入上述浸泡有织物的溶液中。(3) 5.6 g of silver acetate was added to 10 ml of pure water, and the resulting solution was added to the above-mentioned fabric-impregnated solution.
以上操作均在50℃下进行。把上述织物取出,挤干并烘干后,经过切断、包装和灭菌后,得到含银酰化壳聚糖敷料,克重为140gsm。所述含银酰化壳聚糖敷料的吸湿性为26g/100cm 2,按敷料重量计,含银量为0.6重量%,敷料的pH值为6.8。 The above operations were all carried out at 50 °C. The above fabric was taken out, squeezed and dried, and after cutting, packaging and sterilization, a silver-containing chitosan dressing was obtained, and the basis weight was 140 gsm. The silver-containing acylated chitosan dressing had a hygroscopicity of 26 g/100 cm 2 , a silver content of 0.6% by weight based on the weight of the dressing, and a dressing pH of 6.8.
实施例36Example 36
(1)将100g粘胶纤维针织物(克重100gsm)浸泡在上述丙醇胺溶液中,静置30分钟;(1) immersing 100 g of viscose woven fabric (gram weight 100 gsm) in the above propanolamine solution, and letting stand for 30 minutes;
(2)将5.3g乙酸银加到10ml纯水中,然后将所得溶液加入上述浸泡有织物的溶液中。(2) 5.3 g of silver acetate was added to 10 ml of pure water, and then the resulting solution was added to the above-mentioned fabric-impregnated solution.
以上操作均在65℃下进行。把上述织物取出,挤干并烘干后,经切断、包装和灭菌后,得到含银粘胶纤维敷料,克重为100gsm。所述含银粘胶纤维敷料的吸湿性为12g/100cm 2,按敷料重量计,含银量为0.83重量%。敷料的pH值为6.8。本实施例的敷料在金黄色葡萄球菌培养皿1天后的抑菌圈如图7所示,这表明含银的醇胺螯合物的伤口敷料对金黄色葡萄球菌具有一定的抑菌作用。 The above operations were all carried out at 65 °C. The above fabric was taken out, squeezed and dried, and after cutting, packaging and sterilization, a silver-containing viscose fiber dressing was obtained, and the basis weight was 100 gsm. The silver-containing viscose fiber dressing had a hygroscopicity of 12 g/100 cm 2 and a silver content of 0.83 wt% based on the weight of the dressing. The dressing has a pH of 6.8. The inhibition zone of the dressing of this example after 1 day in the S. aureus culture dish is shown in Figure 7, which indicates that the wound dressing of the silver-containing alcohol amine chelate has a certain bacteriostatic effect on Staphylococcus aureus.
实施例37Example 37
(1)将20.23ml乙醇胺溶解到2500ml的无水酒精中,得到乙醇胺溶液;(1) dissolving 20.23 ml of ethanolamine into 2500 ml of anhydrous alcohol to obtain an ethanolamine solution;
(2)将100g厚度为0.8mm的聚氨酯薄膜浸泡在上述乙醇胺溶液中,静置50分钟;(2) 100 g of a polyurethane film having a thickness of 0.8 mm is immersed in the above ethanolamine solution, and allowed to stand for 50 minutes;
(3)将5.6g乙酸银加入到10ml纯水中,然后将所得溶液加入上述浸泡有织物的溶液中。(3) 5.6 g of silver acetate was added to 10 ml of pure water, and the resulting solution was added to the above-mentioned fabric-impregnated solution.
以上操作均在60℃下进行。把上述织物取出,挤干并烘干后,经过切断、包装和灭菌后,得到含银聚氨酯薄膜敷料。所述含银聚氨酯薄膜敷料的吸湿性为8g/100cm 2,按敷料重量计,含银量为0.6重量%。 The above operations were all carried out at 60 °C. The above-mentioned fabric is taken out, squeezed and dried, and after being cut, packaged and sterilized, a silver-containing polyurethane film dressing is obtained. The silver-containing polyurethane film dressing had a hygroscopicity of 8 g/100 cm 2 and a silver content of 0.6% by weight based on the weight of the dressing.
实施例38Example 38
(1)将20.23ml乙醇胺溶解到2500ml的无水酒精中,得到乙醇胺溶液;(1) dissolving 20.23 ml of ethanolamine into 2500 ml of anhydrous alcohol to obtain an ethanolamine solution;
(2)将100g厚度为5mm的聚氨酯泡沫浸泡在上述乙醇胺溶液中,静置50分钟;(2) 100 g of a polyurethane foam having a thickness of 5 mm was immersed in the above ethanolamine solution, and allowed to stand for 50 minutes;
(3)将5.6g乙酸银加入到10ml纯水中,然后将所得溶液加入上述浸泡有织物的溶液中。(3) 5.6 g of silver acetate was added to 10 ml of pure water, and the resulting solution was added to the above-mentioned fabric-impregnated solution.
以上操作均在60℃下进行。把上述织物取出,挤干并烘干后,经过切断、包装和灭菌后,得到含银聚氨酯泡沫敷料。所述含银聚氨酯泡沫敷料的吸湿性为26g/100cm 2,按敷料重量计,含银量为0.6重量%。 The above operations were all carried out at 60 °C. The above fabric is taken out, squeezed and dried, and after being cut, packaged and sterilized, a silver-containing polyurethane foam dressing is obtained. The silver-containing polyurethane foam dressing had a hygroscopicity of 26 g/100 cm 2 and a silver content of 0.6% by weight based on the weight of the dressing.
实施例39Example 39
100gMG型海藻酸钠粉末加入1900g纯水中充分搅拌得到合适的纺丝液,然后在室温下往此纺丝液中加入按照实施例2制备的含银的醇胺螯合物溶液,充分搅拌使其在纺丝液中分散均匀,然后将所得含银纺丝液经过计量泵挤压至喷丝板,然后依次经过凝固浴、热水牵伸、洗涤、干燥、烘干、卷曲和切断工序后,可以得到含银的醇胺螯合物抗菌成分的海藻酸钙纤维,纤维线密度为3dtex,长度为75毫米。经过常规非织造布工序可以得到含银海藻酸钙织物,再经分切、包装和灭菌后可以得到海藻酸钙含银敷料,敷料克重180gsm,吸湿性40g/g,按敷料重量计含银量2.8重量%。敷料的pH值为6.6。本实施例的敷料在金黄色葡萄球菌培养皿3天后的抑菌圈如图8所示,这表明含银的 醇胺螯合物的伤口敷料对金黄色葡萄球菌具有一定的抑菌作用。100 g of MG type sodium alginate powder was added to 1900 g of pure water and stirred well to obtain a suitable spinning solution, and then the silver-containing alcohol amine chelate solution prepared in accordance with Example 2 was added to the spinning solution at room temperature, and the mixture was thoroughly stirred. It is uniformly dispersed in the spinning solution, and then the obtained silver-containing spinning solution is extruded to a spinneret through a metering pump, and then sequentially passed through a coagulation bath, hot water drawing, washing, drying, drying, crimping and cutting processes. A calcium alginate fiber having an antibacterial component of a silver-containing alcohol amine chelate compound having a fiber linear density of 3 dtex and a length of 75 mm can be obtained. After the conventional non-woven fabric process, the silver-containing alginate fabric can be obtained, and then the calcium alginate silver-containing dressing can be obtained after slitting, packaging and sterilization. The dressing weight is 180gsm, the hygroscopicity is 40g/g, and the weight of the dressing is included. The amount of silver was 2.8% by weight. The dressing has a pH of 6.6. The inhibition zone of the dressing of this example after 3 days in the S. aureus culture dish is shown in Fig. 8, which indicates that the wound dressing of the silver-containing alkamine chelate has a certain bacteriostatic action against Staphylococcus aureus.
实施例40Example 40
100g壳聚糖粉末加入适量的2%醋酸溶液中充分搅拌,按照常规方法得到合适的纺丝液,然后在室温下往此纺丝液中加入按照实施例6所制备的含银的醇胺螯合物溶液,充分搅拌使其在纺丝液中分散均匀,将所得含银纺丝液经过计量泵挤压至喷丝板,然后依次经过凝固浴、热水牵伸、洗涤、干燥、烘干、卷曲和切断工序后,可以得到含有含银的醇胺螯合物抗菌成分的壳聚糖纤维,纤维细度为2dtex,长度为60mm。经过常规非织造布工序可以得到含银织物,分切、包装和灭菌后可以得到壳聚糖含银敷料,按敷料重量计,含银量为1.05%,敷料克重120gsm,敷料吸湿性14g/100cm 2。敷料的pH值为7.2。 100 g of chitosan powder is added to an appropriate amount of 2% acetic acid solution and stirred well, a suitable spinning solution is obtained according to a conventional method, and then the silver-containing alcohol amine chelate prepared according to Example 6 is added to the spinning solution at room temperature. The solution is fully stirred to make it evenly dispersed in the spinning solution, and the obtained silver-containing spinning solution is extruded to a spinneret through a metering pump, and then sequentially passed through a coagulation bath, hot water drawing, washing, drying, and drying. After the crimping and cutting steps, a chitosan fiber containing an antibacterial component of a silver-containing alcohol amine chelate compound having a fiber fineness of 2 dtex and a length of 60 mm can be obtained. The silver-containing fabric can be obtained through a conventional nonwoven process. After cutting, packaging and sterilizing, a chitosan-containing silver dressing can be obtained. According to the weight of the dressing, the silver content is 1.05%, the dressing weight is 120gsm, and the dressing moisture absorption is 14g. /100cm 2 . The pH of the dressing was 7.2.
实施例41Example 41
在室温下往常规粘胶纤维纺丝液(固体含量9%)中加入按照实施例8所制备的含银的醇胺螯合物溶液,充分搅拌使其在纺丝液中分散均匀,再将所得含银纺丝液经过计量泵挤压至喷丝板,然后依次经过凝固浴、热水牵伸、洗涤、烘干和切断工序后,可以得到含有醇胺螯合物抗菌成分的粘胶纤维,纤维细度3dtex,长度为50mm。所述含银粘胶纤维经过常规非织造布工序可以得到含银织物,分切、包装和灭菌后可以得到粘胶纤维含银敷料,克重为120gsm,按敷料重量计,含银量为3.06%,敷料吸湿性10g/100cm 2。敷料的pH值为5.6。 Adding the silver-containing alcohol amine chelate solution prepared according to Example 8 to the conventional viscose fiber spinning solution (solid content 9%) at room temperature, stirring well to disperse evenly in the spinning solution, and then The obtained silver-containing spinning solution is extruded to a spinneret through a metering pump, and then passes through a coagulation bath, a hot water drawing, washing, drying and cutting process to obtain a viscose fiber containing an antibacterial component of an alcohol amine chelate. The fiber fineness is 3dtex and the length is 50mm. The silver-containing viscose fiber can obtain a silver-containing fabric through a conventional nonwoven process. After slitting, packaging and sterilization, a viscose fiber-containing silver dressing can be obtained, and the basis weight is 120 gsm. The silver content is based on the weight of the dressing. 3.06%, the dressing moisture absorption is 10g/100cm 2 . The pH of the dressing was 5.6.
实施例42Example 42
把由实施例40制得的含银壳聚糖纤维,与丁二酸酐或者氯乙酸钠进行酰基化或者羧甲基化反应,得到酰化壳聚糖或者羧甲基化壳聚糖纤维,纤维细度为2.1dtex,长度为60mm,经过常规非织造布工序可以得到含银织物,分切、包装和灭菌后可以得到改性壳聚糖含银敷料。所述含银改性壳聚糖敷料的克重为125gsm,吸湿性为22g/100cm 2,按敷料重量计,含银量为0.9重量%。敷料的pH值为7。 The silver-containing chitosan fiber obtained in Example 40 is acylated or carboxymethylated with succinic anhydride or sodium chloroacetate to obtain an acylated chitosan or a carboxymethylated chitosan fiber. The fineness is 2.1 dtex and the length is 60 mm. The silver-containing fabric can be obtained through a conventional nonwoven process, and the modified chitosan silver-containing dressing can be obtained after slitting, packaging and sterilization. The silver-containing modified chitosan dressing had a basis weight of 125 gsm and a hygroscopicity of 22 g/100 cm 2 and a silver content of 0.9% by weight based on the weight of the dressing. The dressing has a pH of 7.
实施例43Example 43
把由实施例41制得的含银粘胶纤维,与氯乙酸钠进行羧甲基化反应,得到羧甲基化纤维素纤维,纤维细度为3.3dtex,长度为50mm,经过常规非织造布工序可以得到含银织物,分切、包装和灭菌后可以 得到改性纤维素纤维含银敷料。所述改性纤维素含银敷料克重为123gsm,吸湿性为26g/100cm 2,按敷料重量计,含银量2.5%。敷料的pH值为6.5。 The silver-containing viscose fiber obtained in Example 41 was subjected to carboxymethylation reaction with sodium chloroacetate to obtain a carboxymethylated cellulose fiber having a fiber fineness of 3.3 dtex and a length of 50 mm, which was passed through a conventional nonwoven fabric. The process can obtain a silver-containing fabric, and the modified cellulose fiber silver-containing dressing can be obtained after slitting, packaging and sterilization. The modified cellulose silver-containing dressing has a basis weight of 123 gsm and a hygroscopicity of 26 g/100 cm 2 and a silver content of 2.5% by weight of the dressing. The dressing has a pH of 6.5.
Claims (21)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710427035.7 | 2017-06-08 | ||
| CN201710427035.7A CN107158030A (en) | 2017-06-08 | 2017-06-08 | A kind of new silver-containing antibacterial product and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2018223743A1 true WO2018223743A1 (en) | 2018-12-13 |
Family
ID=59824992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2018/079095 Ceased WO2018223743A1 (en) | 2017-06-08 | 2018-03-15 | Silver-containing antibacterial product, and preparation method thereof |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN107158030A (en) |
| WO (1) | WO2018223743A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107158030A (en) * | 2017-06-08 | 2017-09-15 | 佛山市优特医疗科技有限公司 | A kind of new silver-containing antibacterial product and preparation method thereof |
| CN108210976A (en) * | 2018-02-05 | 2018-06-29 | 广东泰宝医疗器械技术研究院有限公司 | A kind of preparation method of antibacterial silicone composite foam application |
| CN111455557A (en) * | 2019-01-20 | 2020-07-28 | 泽塔纳米科技(苏州)有限公司 | Antibacterial nanofiber membrane and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010065655A1 (en) * | 2008-12-05 | 2010-06-10 | The Clorox Company | Natural silver disinfectant compositions |
| CN104083800A (en) * | 2014-04-30 | 2014-10-08 | 佛山市优特医疗科技有限公司 | Silver thiosulfate complex or silver-ammonia complex-containing hygroscopic silver-containing product and preparation method thereof |
| CN107158030A (en) * | 2017-06-08 | 2017-09-15 | 佛山市优特医疗科技有限公司 | A kind of new silver-containing antibacterial product and preparation method thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0768094B2 (en) * | 1988-02-26 | 1995-07-26 | 新東工業株式会社 | Antibacterial and antifungal intercalation compound and method for producing the same |
| CN103170004B (en) * | 2012-04-23 | 2016-08-31 | 佛山市优特医疗科技有限公司 | A kind of method preparing contg. silver fiber wound dressing |
| CN103074703A (en) * | 2012-12-03 | 2013-05-01 | 佛山市优特医疗科技有限公司 | Antibacterial silver-containing fiber wound dressing and preparation method thereof |
| CN104958779B (en) * | 2015-06-25 | 2018-03-20 | 佛山市优特医疗科技有限公司 | A kind of wound dressing containing chelating silver fiber |
| CN105709262A (en) * | 2016-03-16 | 2016-06-29 | 张家港耐尔纳米科技有限公司 | Silver-loaded antibacterial dressing and preparation method thereof |
-
2017
- 2017-06-08 CN CN201710427035.7A patent/CN107158030A/en not_active Withdrawn
-
2018
- 2018-03-15 WO PCT/CN2018/079095 patent/WO2018223743A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010065655A1 (en) * | 2008-12-05 | 2010-06-10 | The Clorox Company | Natural silver disinfectant compositions |
| CN104083800A (en) * | 2014-04-30 | 2014-10-08 | 佛山市优特医疗科技有限公司 | Silver thiosulfate complex or silver-ammonia complex-containing hygroscopic silver-containing product and preparation method thereof |
| CN107158030A (en) * | 2017-06-08 | 2017-09-15 | 佛山市优特医疗科技有限公司 | A kind of new silver-containing antibacterial product and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107158030A (en) | 2017-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015165400A1 (en) | Hygroscopic silver-containing product containing silver thiosulfate complex or silver-ammonia complex, and preparation method thereof | |
| CN104080487B (en) | Antibiotic property Wound covering material and preparation method thereof | |
| ES2773280T3 (en) | Production method of an inflatable polymer fiber | |
| Lu et al. | In situ reduction of silver nanoparticles by chitosan-l-glutamic acid/hyaluronic acid: Enhancing antimicrobial and wound-healing activity | |
| CN102453968B (en) | Containing antibiotic fiber, the fabric and wound dressing and preparation method thereof of nano metal | |
| JP2777279B2 (en) | Wound dressing and method for producing the same | |
| EP2842580B1 (en) | Silvery antibacterial fibre, texture, and wound dressing, and preparation method thereof | |
| WO2012136082A1 (en) | A chitosan wound dressing and its method of manufacturing | |
| WO2012106983A1 (en) | Antibacterial fibrous dressing containing nano-sized metal and preparation method thereof | |
| CN102552964B (en) | Nano silver chitosan composite antibacterial composition, adhesive bandage and preparation method of adhesive bandage | |
| CN107385917B (en) | Antibacterial alginate fiber, preparation method and application of dressing thereof | |
| WO2014086186A1 (en) | Antibacterial silver-containing fiber wound dressing and preparation method thereof | |
| CN100411690C (en) | A kind of preparation method of antibacterial polyelectrolyte porous material | |
| WO2018223743A1 (en) | Silver-containing antibacterial product, and preparation method thereof | |
| CN111068103B (en) | A kind of long-acting antibacterial gel dressing for surgical wound and preparation method thereof | |
| JP4826382B2 (en) | Antibacterial cellulose fiber and textile product for skin contact | |
| CN108578749A (en) | A kind of medical compound pomelo-pectin sponge dressing and its preparation method and application of medicine-carried sustained release | |
| CN108042839A (en) | A kind of chitosan complexes bandage and preparation method thereof | |
| CN104922719A (en) | Preparation method for nano-silver anti-bacterial soluble gauze not loaded with silver chloride | |
| GB2588442A (en) | Antimicrobial material | |
| JPH01270871A (en) | Bandage for wound | |
| CN114959946A (en) | Gel type durable antibacterial calcium alginate fiber and preparation method thereof | |
| CN118892570A (en) | A regenerated oxidized cellulose composite hemostatic material and preparation method thereof | |
| Long et al. | Biomaterials Advances |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18813151 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 18813151 Country of ref document: EP Kind code of ref document: A1 |